Antiviral Responses in Mouse Embryonic Stem Cells: Differential Development of Cellular Mechanisms in Type I Interferon Production and Response by Wang, Ruoxing
The University of Southern Mississippi
The Aquila Digital Community
Dissertations
Summer 8-2014
Antiviral Responses in Mouse Embryonic Stem
Cells: Differential Development of Cellular
Mechanisms in Type I Interferon Production and
Response
Ruoxing Wang
University of Southern Mississippi
Follow this and additional works at: https://aquila.usm.edu/dissertations
Part of the Cell Biology Commons, Developmental Biology Commons, Immunity Commons,
Molecular Biology Commons, and the Virology Commons
This Dissertation is brought to you for free and open access by The Aquila Digital Community. It has been accepted for inclusion in Dissertations by an
authorized administrator of The Aquila Digital Community. For more information, please contact Joshua.Cromwell@usm.edu.
Recommended Citation
Wang, Ruoxing, "Antiviral Responses in Mouse Embryonic Stem Cells: Differential Development of Cellular Mechanisms in Type I
Interferon Production and Response" (2014). Dissertations. 11.
https://aquila.usm.edu/dissertations/11

The University of Southern Mississippi
ANTIVIRAL RESPONSES IN MOUSE EMBRYONIC STEM CELLS: 
DIFFERENTIAL DEVELOPMENT OF CELLULAR MECHANISMS
IN TYPE I INTERFERON PRODUCTION AND RESPONSE
by
Ruoxing Wang
Abstract of a Dissertation
Submitted to the Graduate School
of The University of Southern Mississippi
in Partial Fulfillment of the Requirements
for the Degree of Doctor of Philosophy
August 2014
ABSTRACT
ANTIVIRAL RESPONSES IN MOUSE EMBRYONIC STEM CELLS:
DIFFERENTIAL DEVELOPMENT OF CELLULAR MECHANISMS
IN TYPE I IFN PRODUCTION AND RESPONSE
by Ruoxing Wang
August 2014
Embryonic stem cells (ESCs) have been recognized as a promising cell source for 
regenerative medicine. Intensive research over the past decade has led to the possibility 
that ESC-derived cells will be used for the treatment of human diseases. However, 
increasing evidence indicates that ESC-derived cells generated by the current 
differentiation methods are not fully functional. It is recently recognized that ESC-
derived cells lack innate immunity to a wide range of infectious agents and inflammatory 
cytokines. When used in patients, ESC-derived cells would be placed in wounded sites 
that are exposed to various pathogens and inflammatory cytokines; therefore, their 
viability and functionality would be significantly compromised if the cells do not have 
competent immunity. The responses of mESCs to three types of live viruses, La Crosse 
virus, West Nile virus, and Sendai virus, were firstly investigated. The results 
demonstrated that mESCs were susceptible to the viral infections, but they were unable to 
express type I interferons (IFNα and IFNβ). The failure of mESCs to express IFNα/β was 
further demonstrated with polyIC (polyinosinic-polycytidylic acid), a synthetic viral 
dsRNA analog that strongly induced IFNα/β in 10T1/2 cells. The author conclude that the 
mechanisms that mediate type I IFN expression are deficient in mESCs. It will be further 
demonstrated that single stranded RNA and 
ii
protein encoding mRNA induce strong IFN expression and cytotoxicity in fibroblasts and 
cancer epithelial cells, but none of these effects associated with antiviral responses was 
observed in ESCs. Therefore, ESCs are intrinsically deficient in antiviral responses; in 
particular, they do not have functional mechanisms to express type I IFN. Furthermore, 
the author found that mESCs can respond to type I IFNs and express IFN-stimulated 
genes as in differentiated fibroblasts. IFNβ and IFNω can protect mESCs from La Crosse 
virus -induced cell death and inhibit the replication of LACV and West Nile Virus. In 
summary, these findings illustrated that the cellular mechanisms for production of and 
response to type I IFN are not equally developed in mESCs; they are deficient in type I 
IFN expression but have functional mechanisms that respond to and mediate the antiviral 
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Introduction of Embryonic Stem Cells and Related Research 
Embryonic stem cells: isolation and their differentiation potential 
Thirty years ago, Evans and Kaufman isolated and established the first 
embryonic stem cell (ESC) line from mouse embryos (Evans & Kaufman, 1981; Martin, 
1981). As shown by Figure 1, ESCs are derived from pre-implantation stage embryos 
called blastocysts which consist of outer trophoblast cells and a group of inner 
undifferentiated cells referred to as the inner cell mass (ICM) (Wobus & Boheler, 2005). 
ESCs cultured in vitro can maintain properties of ICM cells and retain the potential to 
differentiate into all cell types of three germ layers in the embryo: ectoderm, mesoderm 
and endoderm. The fertilized egg and its early progeny (up to the 8-cell morula phase) 
have the ability to give rise to all cell types of the body as well as extra-embryonic 
tissues, a property known as totipotency, while cells from the ICM and ESCs are termed 
pluripotent, as they can only give rise to cell types of the embryo proper (Wobus & 
Boheler, 2005), not extra-embryonic tissues.  
The differentiation potential of ESCs has been demonstrated both in vivo and 
in vitro. When introduced into blastocysts, exogenous ESCs could contribute to all cell 
lineages in three germ layers and the germ line in the resulting mouse chimeras (Bradley, 
Evans, Kaufman, & Robertson, 1984). The contribution to chimera formation is used as 
the gold standard for pluripotent cell lines. On the other hand, when induced in vitro, 
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ESCs can differentiate into various somatic cell types and cells in the germ line 
(Doetschman, Eistetter, Katz, Schmidt, & Kemler, 1985; Geijsen et al., 2004; Hubner et 
al., 2003; Toyooka, Tsunekawa, Akasu, & Noce, 2003; Wobus, Holzhausen, Jakel, & 
Schoneich, 1984). Once established, ESCs display an infinite capacity to proliferate and 
retain the differentiation potential to all cell lineages in vitro under proper conditions 
(Smith, 2001). The process through which ESCs reproduce themselves and maintain 
pluripotency is termed as self-renewal. This feature makes ESCs an ideal unlimited 
source for regenerative medicine and cell therapy.  
Aside from potential medical applications of ESCs, these cells also have great 
value for studying gene functions and developmental biology. Several powerful 
technologies of gene manipulation have been successfully applied in ESCs, including 
overexpressing genes through random transgenesis, gene targeting to knock out genes or 
replace wild-type with mutant genes, and conditional knock-out and knock-in techniques 
(Gossler, Joyner, Rossant, & Skarnes, 1989; Lewandoski, 2001; Nagy, 2000; Thomas & 
Capecchi, 1987; Thompson, Clarke, Pow, Hooper, & Melton, 1989). Based on gene 
targeting, transgenic animal models can be established through re-introducing 
manipulated ESCs back into blastocysts to get heterozygous offspring with one mutated 
allele, followed by mating between heterozygous animals to obtain homozygous mutant 
offspring. These models have revealed functions of a great number of genes throughout 
the developmental process. The ESCs isolated from embryos of homozygous mutant 
animals can be studied in vitro even when in vivo studies are impossible because of 
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embryonic lethality. Targeting genes in chromosome pairs sequentially in ESCs is much 
less labor intensive and has proved indispensable in elucidating gene function. One 
example is the characterization of the Nanog gene in ESCs (Mitsui et al., 2003).  
 
Figure 1. Derivation and differentiation potential of embryonic stem cells (Jones, 2006). 
ESC based cell therapy and regenerative medicine: promises and challenges 
ESCs have unlimited capacity for self-renewal and can be induced to 
differentiate into various cell lineages. These properties make them a promising source 
for cell-based therapy. The recent extensive research has led to the development of 
methods for ESC differentiation to different cell types. While these advances have 
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proven the principles of ESC-based cell therapy, it is also increasingly clear that 
generating clinically usable cells is a task that faces many biological and technical 
challenges. No ESC-derived cell preparations have so far been approved for medical 
application. Current knowledge about the basic physiology of ESCs is limited, and there 
are many safety issues that have yet to be resolved. 
Mouse ESCs proliferate rapidly with truncated cell cycle times of 10-15 h (White 
& Dalton, 2005). During in vitro culture, ESCs display unlimited proliferative capacity 
(Suda, Suzuki, Ikawa, & Aizawa, 1987), clonal propagation, anchorage independence, 
and a lack of contact inhibition (Burdon, Chambers, Stracey, Niwa, & Smith, 1999). 
These features are shared by many malignant cells. It is well recognized that if ESCs are 
not fully differentiated and transplanted to the patient, they can grow into tumor-like 
structures known as teratomas (Stevens, 1983; Wobus et al., 1984). However, most 
current differentiation protocols fail to eliminate all undifferentiated cells. This 
phenomenon is proved by the fact that in animal models, transplantation of ESC-derived 
differentiated cells still results in teratoma formation, presumably by undifferentiated 
ESCs (Blyszczuk et al., 2003; Kim et al., 2002). Many other issues have not been fully 
recognized. Currently, ESC-derived cells are mainly identified by cell-specific markers, 
which may reveal little of their functionality. 
Until now, most knowledge about ESCs was derived from mouse ESCs 
(mESCs). Human ESCs (hESCs) isolated later have been shown to share some 
fundamental characteristics of murine cell lines such as telomerase activity, Oct-4 
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expression, and differentiation potential to three germ layers (Richards, Fong, Chan, 
Wong, & Bongso, 2002; Thomson et al., 1998). Also, hESCs can maintain proliferative 
potential and a normal karyotype for long periods of culture (Amit et al., 2000).  
However, hESCs differ from mESCs in cell cycle time (30-35 h vs 10-15 h) 
and culture requirements (Amit et al., 2000; Reubinoff, Pera, Fong, Trounson, & Bongso, 
2000; Thomson et al., 1998). Moreover, activation of the JAK/STAT3 pathway by LIF 
(which shares a similar signaling paradigm with IFN) is essential for the maintenance of 
self-renewal and pluripotency in mESCs but is not required for hESCs (Daheron et al., 
2004; Humphrey et al., 2004; Matsuda et al., 1999). Whether the differences between 
human and mouse ESCs are caused by a difference between species or that in developing 
phases is still not clear, and the mechanisms behind remains elusive.  
During long term in vitro culture, there is no guarantee of the genetic stability 
of ESCs. Somatic cells accumulate approximately one mutation through each turn of the 
cell cycle (Kunkel & Bebenek, 2000). Aside from gene mutation, in vitro environments 
can also change epigenetic modifications which play important roles in the 
developmental potential of ESCs. Stresses and potential contamination also need to be 
taken into consideration. A thorough understanding of mechanisms governing such ESC 
behaviors as self-renewal, proliferation, and differentiation is needed to improve the 




Impacts of ESC research on basic research, cell biology, and development biology  
Organismal development from the zygote to an adult is the most complex 
biological process and is far from being elucidated. Differentiation from totipotent to 
various somatic cells is the basis of development. During differentiation, cells undergo 
global epigenetic changes resulting in new expression patterns of genes with special 
functions. The study of how epigenetic states and expression of numerous genes are 
regulated in early embryonic cells has greatly benefited from ESC research. ESCs, the in 
vitro counterpart of pluripotent cells in the early embryos, have proved a valuable model 
to investigate how “stem” and “differentiation” genes are regulated during differentiation 
(Bernstein et al., 2006; Guenther et al., 2010; Guenther, Levine, Boyer, Jaenisch, & 
Young, 2007; Lee et al., 2006). These data obtained from such investigations are 
fundamental to elucidate the mechanisms involved in cell differentiation, tissue 
formation, and organismal development.  
Studies of ESCs showed that they share many features with cancer cells such 
as infinite proliferation ability, rapid cell cycle progression, deficient cell cycle 
checkpoints, and anchorage-independent growth (White & Dalton, 2005). However, 
while keeping such tumor characteristics, ESCs have much a lower spontaneous 
mutation rate and a higher tolerance and resistance to exogenous stresses (Hong, 
Cervantes, Tichy, Tischfield, & Stambrook, 2007; Maynard et al., 2008; Saretzki et al., 
2008). The similarities between cancer cells and ESCs in fact brought about the “cancer 
stem cell” hypothesis, which states that not all cancer cells are the same and a particular 
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population of cancer cells has the unique properties like ESCs that give rise to all cell 
types in a particular cancer type with invasive capacity. Therefore, the study of ESCs has 
provided a model to help understand cancer biology and disease modeling. Special 
regulation of proliferation and maintenance of genetic integrity makes ESCs a valuable 
model when sdudying mechanisms governing cell propagation, response to stress and 
genetic stability, and how these mechanisms are altered in cancer cells (Lin, Donahue, & 
Ruley, 2006; Tichy & Stambrook, 2008).  
Innate Immunity and Type I IFN Signaling 
Many types of adult somatic cells in organisms are exposed to external 
environments containing various pathogenic microorganisms. To protect the whole 
organism from infection, a sophisticated immune system comprised of immune cells that 
specifically recognize pathogens and non-specific innate immunity has been established 
in vertebrates. After exposure to components of pathogens like bacterial 
lipopolysaccharide (LPS) or viral RNA, several signaling pathways are activated, leading 
to changes in metabolism and gene expression in infected cells. Consequential immune 
responses are then activated to limit and remove pathogenic infection. So, the overall 
immune response begins with innate immune system activation in infected cells and 
continues with innate or specific immunity of immune cells.  
While most differentiated somatic cells have already established innate immunity, 
understanding how ESCs respond to pathogens is not only interesting in stem cell 
biology but also valuable for their application in cell therapy. Will pathogen exposure and 
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the responses of ESCs affect their stem cell state? When and how is innate immunity 
established during differentiation? Could innate immunity be normally established during 
differentiation of cultured ESCs? To answer these questions, the responses of ESCs to 
pathogens should be thoroughly investigated.  
 
Figure 2. Type I IFN in anti-viral innate immunity. Pathogen recognition receptors (PRRs) 
detecting viral components transduce signaling to activate transcription factors: 
interferon-regulatory factor 3 (IRF3), interferon-regulatory factor 7 (IRF7) and nuclear 
factor-κB (NFκB), which induce expression of type I IFN. After being synthesized and 
secreted, type I IFNs bind their receptors, activate downstream signaling, mediate 
expression of IFN-stimulated genes (ISGs) and finally initiate an anti-viral effector 
program (Bowie & Unterholzner, 2008). 
As shown in Figure 2, various receptors recognize invading components and 
transduce signals to trigger expression of type I IFNs (IFNα/β) and inflammatory 
cytokines. Then, these cytokines induce further cellular events in infected and 
neighboring cells and recruit immune cells. Detailed information about the type I IFN 
signaling will be introduced in corresponding sections. 
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Innate Immunity in ESCs 
Most studies of innate immunity are done in differentiated somatic cells, 
especially in cells with immune-related roles. It is not clear whether innate immunity 
exists in early embryos, or how and when innate immunity is established during 
development.  
Since ESCs are a promise source for regenerative medicine, their differentiated 
progeny should be fully functional to meet medical and physiological demands. Innate 
immunity is a pivotal function of hematopoietic cells, vascular cells, and cells directly 
exposed to the environment. Recent studies have shown that hESCs, unlike somatic cells, 
exhibit an attenuated response to dsRNA (Chen, Yang, & Carmichael, 2010). Expression 
of immune sensors is low or undetectable in hESCs, and induction of cytokines is much 
weaker than in somatic cells (Chen et al., 2010). Moreover, cellular localization of 
dsRNA in hESCs is different from in differentiated cells (Chen et al., 2010). hESCs were 
also found to express few TLR members and do not respond to TLR ligands. What is 
more interesting is that even hESC-derived endothelial cells and cardiomyocytes after 4 
months of differentiation respond poorly to pathogen associated molecular patterns, 
(PAMP) compared with primary human aortic endothelial cells (HAEC) (Foldes et al., 
2010).  
It is also interesting to note that a recent study suggested that hESCs and human 
induced pluripotency stem cells (hiPSCs) have limited or no capacity to respond to IFN 
(Hong & Carmichael, 2013). 
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In summary, how ESCs respond to PAMPs is still elusive, and data about the 






















OBJECTIVE AND SIGNIFICANCE 
ESCs have unlimited capacity for self-renewal and can be induced to differentiate 
into any cell lineage (Wobus & Boheler, 2005). These properties make them a promising 
source for cell-based regenerative medicine. The extensive research over the past decade 
has led to the development of methods for ESC differentiation to various cell types. 
These advances have proven the principles of ESC-based cell therapy. However, it is also 
increasingly clear that generating clinically usable cells is a task filled with many 
biological and technical challenges. For example, while it is well-recognized that if ESCs 
are not fully differentiated and transplanted to the patient, they can grow into tumor-like 
structures called teratomas; some other potential problems have not yet been fully 
recognized (Stevens, 1983). Currently, ESC derived cells are mainly identified by 
cell-specific markers which may reveal little about their functions. An important issue is 
innate immunity, which is not easily recognized in normal cells without challenge from 
infectious agents. Only a few studies, including our own, have investigated the innate 
immunity and inflammation responses of ESC-derived cells (Wang et al., 2013). Such 
studies have demonstrated that endothelial cells and smooth muscle cells derived from 
both human and mouse ESCs have limited ability to respond to viral related infectious 
agents, LPS, and inflammatory cytokines (Foldes et al., 2010; Glaser et al., 2011). The 
deficiency in the immune and inflammatory responses is likely found in most, if not all, 
types of ESC-derived cells as indicated by my recent data. Therefore, the objective of my 
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work is to investigate the innate immunity of undifferentiated mESCs. The author 
hypothesize that undifferentiated ESCs do not have fully functional innate immunity, 
which is supposed to be established in somatic cells. 
While ESC research has led to a great expectation that ESC-derived cells could 
soon be used for regenerative medicine, in reality these cells will not become clinically 
beneficial if they cannot perform the essential functions of their in vivo counterparts. The 
molecular mechanisms regulating proliferation, pluripotency, and self-renewal have been 
the center of ESCs research for the past decade. However, developing strategies for 
functional ESC-derived cells usable for clinical application may mark the beginning of a 
new era of ESC research. Innate immunity is an important function of normal in vivo 
differentiated somatic cells; therefore, studying its development may contribute to the 
design of differentiation strategies that generate cell lineages with active innate immunity. 
Moreover, understanding the development of innate immunity during differentiation will 
be not only instructive for the derivation of many cell types from ESCs with competent 




MOUSE EMBRYONIC STEM CELLS ARE DEFICIENT IN TYPE I INTERFERON 
EXPRESSION IN RESPONSE TO VIRAL INFECTIONS  
AND DOUBLE-STRANDED RNA 
Introduction 
The anti-viral immune response, which is centered on type I IFN production and 
response, starts with the recognition of specific pathogen associated molecular patterns 
(PAMPs) by pattern recognition receptors (PRR), and induction of type I IFNs is the 
central part of innate immunity. There are various PRRs and pathways leading to 
production of type I IFNs. 
Toll-like receptors 
Toll-like receptors (TLRs) are a family of conserved transmembrane proteins with 
critical roles in innate immunity (Akira, Uematsu, & Takeuchi, 2006). TLRs expressed at 
the cellular membrane or membranes of the intracellular organelles and endocytic 
vesicles recognize various microbial molecular structures such as LPS, lipopeptides, viral 
nucleic acids (Akira et al., 2006). TLRs are type I integral transmembrane glycoproteins 
containing extra-membrane domains and an intra-membrane domain homologous to the 
intracellular domain of interleukin 1 receptor (IL-1R) (Bowie & O'Neill, 2000). Different 
TLR members have different cellular locations. While TLR1, 2, 4, 5, and 6 are found on 
the cell membrane, TLR3, 7, 8, and 9 are expressed almost exclusively on the 
membranes of endosomes (Akira et al., 2006).  
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TLRs with various primary sequences recognize diverse microbial targets and can 
be divided into several subclasses.  
 
Figure 3. Toll-like receptor signaling. TLRs localized on the cellular membrane and 
endosomes recognize various pathogen components, form dimers and finally activate two 
important families of transcription factors: nuclear factor-κB (NF-κB) and the 
interferon-regulatory factors (IRFs), leading to induction of Type I IFN and 
pro-inflammatory cytokines (Bowie & Unterholzner, 2008). 
LPS, a best studied bacterial endotoxin, is recognized by TLR4, leading to their 
oligomerization (Poltorak et al., 1998; Shimazu et al., 1999). Unlike Gram negative 
bacteria, Gram positive bacteria do not synthesize LPS but still can be recognized by 
innate immunity. TLR2, in some cases together with TLR1 and TLR6, recognizes 
bacterial components such as lipoproteins, peptidoglycan (PG), and lipoteichoic acid 
(LTA) (Alexopoulou et al., 2002; Ozinsky et al., 2000; Takeuchi et al., 2001; Takeuchi et 
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al., 2002). Flagellin, the major component of flagella, is also a potent activator of innate 
immunity. TLR5 which is responsible for this process recognizes a conserved and 
constant domain of flagellin (Hayashi et al., 2001). TLR9 recognizes bacterial genome 
DNA and triggers the innate immune response (Hemmi et al., 2000).  
Mycobacterial cell wall components, lipomannan (LM), and lipoarabinomannan 
(LAM) have been shown to activate TLR2 and TLR4, and LAM captured by a 
phosphoinositide residue (PILAM) is a potent stimulator of TLR2 (Akira et al., 2006; 
Gilleron, Quesniaux, & Puzo, 2003). In addition, TLR2 together with TLR1 can 
recognize cell-wall associated lipoprotein in M. tuberculosis (Thoma-Uszynski et al., 
2001).  
 Several cell wall components are recognized by TLR2 and TLR4. TLR4 knockout 
mice showed increased susceptibility to disseminated Candida infection, while TLR2 
null mice exhibited increased resistance (Netea, Van der Graaf, Van der Meer, & 
Kullberg, 2004). Although TLR-induced signals activate Th1-directed responses that are 
critical for protection against fungi, TLR2 activation is less inflammatory and leads to 
Th2 response through inducing IL-10 expression (Agrawal et al., 2003). A 
trans-membrane protein Dectin-1 collaborates with TLR2 to elicit a strong inflammatory 
response through recruitment of the protein tyrosine kinase Syk in response to yeast 
(Gantner, Simmons, Canavera, Akira, & Underhill, 2003; Rogers et al., 2005; Underhill, 
Rossnagle, Lowell, & Simmons, 2005).  
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Components of protozoan parasites are also sensed by TLRs. 
Trypanosoma-derived molecules, glycosylphosphatidylinositol mucin (tGPI-mucin), 
glycoinositolphospholipids (GIPLs), and genomic DNA could activate TLR2, 4, 9 
respectively (Gazzinelli, Ropert, & Campos, 2004). TLR11 has been reported to 
recognize a profilin-like molecule in the exact from T. gondii tachyzoites (Yarovinsky et 
al., 2005). In addition, some non-DNA molecules have been shown to activate TLR9 
(Coban et al., 2005; Pichyangkul et al., 2004).  
 Besides bacteria and protozoans, viruses also activate innate immunity through 
multiple TLRs and other receptors. 
Aside from bacterial DNA, TLR9 also recognizes viral DNAs. DNA viruses as 
herpes simplex virus 1 (HSV-1), HSV-2, and murine cytomegalovirus (MCMV) with 
genomes rich in CpG-motifs induce expression of IFN and inflammatory cytokines 
through binding TLR9 (Hochrein et al., 2004; Krug et al., 2004a; Krug et al., 2004b; 
Lund, Sato, Akira, Medzhitov, & Iwasaki, 2003). Mouse TLR7 and human TLR8 
recognize uridine-rich or uridine/guanosine-rich single-stranded RNA of both viral and 
host origins (Diebold, Kaisho, Hemmi, Akira, & Reis e Sousa, 2004; Heil et al., 2004; 
Hemmi et al., 2002). Double-stranded RNA (dsRNA) and its analog, 
polyinosinic-polycytidylic acid (poly I:C), are potent activators of TLR3 and inducers of 
type I IFN (Alexopoulou, Holt, Medzhitov, & Flavell, 2001). However, several lines of 
evidence indicate that TLR3 is not required for initial, cell-autonomous recognition of 
viral infection, and the first wave of type I IFN induction (Lopez et al., 2004). TLR3 
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knockout mice do not exhibit increased susceptibility to MCMV, lymphocytic 
choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV), and reovirus infection 
(Edelmann et al., 2004). These findings may indicate the existence of other components 
for dsRNA recognition. Components of viral envelope also have been shown to activate 
TLRs such as TLR2 and TLR4. For instance, TLR4 can recognize the fusion protein from 
respiratory syncytial virus (RSV) causing infiltrating inflammation (Kurt-Jones et al., 
2000). TLR2 can also be activated by viral components as measles virus (MV) 
hemagglutinin, human CMV, and HSV-1 (Bieback et al., 2002; Compton et al., 2003).  
After ligand binding, TLRs dimerize and undergo conformational changes, 
leading to the recruitment of their adaptors, including MyD88, TIR-associated protein 
(TIRAP)/MyD88- adaptor-like (MAL), TIR-domain-containing adaptor protein- inducing 
IFN-β (TRIF)/TIR-domain-containing molecule 1 (TICAM1), and TRIF-related adaptor 
molecule (TRAM) (Akira et al., 2006; Oshiumi, Matsumoto, Funami, Akazawa, & Seya, 
2003; Yamamoto et al., 2002b).  
Upon activation of TLRs, MyD88 associates with the intracellular domain of 
TLRs and recruits IL-1R associated kinase 4 (IRAK4) and IRAK1 (Akira et al., 2006). 
TLR2 and TLR4 require another adaptor, TIRAP/Mal to recruit MyD88 (Fitzgerald et al., 
2001; Horng, Barton, Flavell, & Medzhitov, 2002; Horng, Barton, & Medzhitov, 2001; 
Yamamoto et al., 2002a). IRAK1 then is phosphorylated by IRAK4 and associates with 
TNFR-associated factor 6 (TRAF6), an E3 ubiquitin ligase (Li, Strelow, Fontana, & 
Wesche, 2002). TRAF6 then promotes the formation of K63-linked polyubiquitin chain 
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on TRAF6 itself and on IKK-g/NF-kB essential modulator (NEMO) (Deng et al., 2000). 
At the same time, TRAF6 also recruits a complex composed of TGF-β-activated kinase 1 
(TAK1) and the TAK1 binding proteins TAB1, TAB2, and TAB3 (Wang et al., 2001). 
This complex phosphorylates IKK-β and MAPK kinase 6 (MKK6) to modulate the 
activity of NF-κB and MAPK pathway (Wang et al., 2001).  
 In addition, after TLR activation transcription factor IRF-5 translocates to the 
nucleus and binds promoter regions of cytokine genes, leading to their up-regulation 
(Takaoka et al., 2005). IκBζ is rapidly induced by TLR binding to ligands and associates 
with NF-κB p50 to stimulate expression of inflammatory cytokines such as IL-6 and 
IL-12 (Yamamoto et al., 2004).  
Another set of important downstream genes induced by TLRs is type I IFN. IFN 
is induced by TLR3, 4, 7 and 9 ligands (Akira et al., 2006). One way to activate IFN 
transcription is through activation of NF-κB pathway via MyD88. The other pathway, 
which is MyD88–independent, can be triggered by TLR3 and TLR4 (Kaisho, Takeuchi, 
Kawai, Hoshino, & Akira, 2001). This MyD88 independent pathway is mediated by 
another TRIF and, in the case of TLR4, assisted by TRAM, which bridges TLR4 and 
TRIF (Fitzgerald et al., 2003b; Hoebe et al., 2003; Yamamoto et al., 2003a; Yamamoto et 
al., 2003b). Upon TLR activation, TRIF interacts with receptor-interacting protein 1 
(RIP1) and, on the other hand, activates TRAF family-member-associated NF-kB 
activator (TANK) binding kinase 1 (TBK1; also known as NAK or T2K) via TRAF3 
(Hacker et al., 2006; Meylan et al., 2004; Oganesyan et al., 2006). TBK1 consists of a 
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family of inducible IκB kinase (IKK-ε) which directly phosphorylates IRF-3 and IRF-7 
(Fitzgerald et al., 2003a; Sharma, 2003). IRF-3 and IRF-7 are essential for type I IFN 
induction as evidenced by the abrogation of virus-induced IFN production in IRF3/7 
knockout cells (Honda et al., 2005).  
In addition, IRF7, in some circumstances, also contributes to IFN induction in a 
MyD88-dependent manner with IRAK-1, IRAK-4, and TRAF-6 (Honda et al., 2004; 
Kawai et al., 2004).  
RIG-I like receptor (RLR) family 
TLRs are able to recognize dsRNA and stimulate type I IFN expression; however, 
most virus-infected cells produce IFN in a TLR-independent manner (Akira et al., 2006). 
Retinoic acid inducible protein I (RIG-I) containing CARD domains and a DExD/H box 
helicase domain serves as a cytoplasmic dsRNA sensor (Yoneyama et al., 2004). 
Melanoma differentiation associated gene 5 (MDA5), which is homologous to RIG-I, has 
also been implicated in recognizing dsRNA (Andrejeva et al., 2004; Kang et al., 2002). 
These two proteins belong to the RIG-I like receptor (RLR) family. Another member of 
this family is LGP2, which has a homologous helicase domain but lacks CARD 
(Rothenfusser et al., 2005; Yoneyama et al., 2005). LGP2 is considered to be a negative 
regulator of RIG-I and MDA5. 
 Although similar in structure, RIG-I and MDA5 have been shown to play 
different roles in recognizing RNA viruses (Kato et al., 2005). Some viruses activate only 
one of them while some are recognized by both (Eisenaher & Krug, 2012). 
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 Besides dsRNA, RIG-I can also be activated by exogenous and microbial DNA. 
This process is mediated by RNA polymerase III that transcribes the DNA to RNA 
recognizable for RIG-I (Ablasser et al., 2009; Chiu, Macmillan, & Chen, 2009). These 
DNAs are transcribed in great amount by host RNA pol III to activate RIG-I. 
Recognition of ssRNA by RIG-I depends on the 5’ tri-phosphate motif in ssRNA 
(Hornung et al., 2006; Pichlmair et al., 2006). This recognition mechanism may provide a 
method to distinguish host RNAs from viral RNAs (Rmos & Gale, 2011).  
 
Figure 4. Signaling transduction of RLRs. RLRs bind MAVS on the surface of 
mitochondria and induces activation of IKK and TBK1, stimulating nuclear factor 
(NF)-κB and interferon (IFN) regulatory factor (IRF)–dependent pathways respectively. 
(Yajima & Knowlton, 2009) 
 Shortening synthesized dsRNA polyIC shifts its recognition by MDA5 to RIG-I, 
suggesting that MDA5 may prefer dsRNA with longer base pairs (Kato et al., 2008). 
Recent data indicate that higher order dsRNA “web” structure is responsible for MDA5 
activation rather than simply long length (Kato et al., 2008; Pichlmair et al., 2009).  
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As shown in Figure 4, upon activation and dimerization of RLRs, adapter protein 
IFN-β promoter stimulator 1 (IPS-1) with CARDs binds RLRs and transduces signals 
(Kawai et al., 2005). This protein is independently found and named mitochondrial 
antiviral signaling protein (MAVS), virus-induced signaling adapter (VISA), and CARD 
adapter inducing IFN-β (CARDIF) (Meylan et al., 2005; Seth, Sun, Ea, & Chen, 2005; 
Xu et al., 2005). Overexpression of IPS-1enhances RLR mediated immune response, 
while IFN induction by RIG-I- or MDA5- recognized viruses is impaired in IPS-1 null 
mice, indicating its essential roles (Kumar et al., 2006; Sun et al., 2006). In addition to 
receptor-adaptor interaction, the function of IPS-1 relies on its localization at the outer 
membrane of mitochondria (Seth et al., 2005).  
 In addition to mitochondria localization, IPS-1 has also been found in 
peroxisomes (Dixit et al., 2010). This population mainly induces rapid IRF1/3 dependent 
expression of IFN stimulated genes (ISGs), leading to an early but transient anti-viral 
response independent of type I IFN (Dixit et al., 2010).  
Upon CARD-CARD interaction between receptors and adaptors, tumor necrosis 
factor receptor-associated factor (TRAF) family members are required. Interaction of 
IPS-1 with TRAF3 through its TRAF-interacting motif (TIM) is essential for IPS-1 
dependent IFN induction (Saha et al., 2006). On the other hand, TRAF2 and TRAF6 
interact with IPS-1 to induce NF-κB activation (Xu et al., 2005). The downstream of 
IPS-1, TRAFs transmit signals to the protein kinase inhibitor of NF-κB (IκB) kinase 
complex composed of NEMO(IKKγ):IKKα:IKKβ. Then, the kinase complex 
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phosphorylates IκB, promoting its degradation and NF-κB nuclear translocation and 
activation (Karin & Ben-Neriah, 2000; Xu et al., 2005).  
As shown in Figure 4, IPS-1 activates IRF3 and IRF7 in parallel through two IKK 
related kinases: TBK1 and IKKi (Honda & Taniguchi, 2006). Phosphorylated IRF3 and 
IRF7 form homo-/heterodimers that translocate to nucleus and induce type I IFN 
expression (Honda & Taniguchi, 2006; Honda et al., 2005). Furthermore, NEMO, with 
essential functions in RLR-induced NF-κB activation, also contributes to 
TBK/IKKi-induced IRF activation (Zhao et al., 2007). 
Moreover, Fas-associated death domain (FADD) and receptor interacting protein 
1 (RIP1) associate with IPS-1 and recruit caspase 8 and 10, activating downstream 
NF-κB signaling (Balachandran, Thomas, & Barber, 2004; Takahashi et al., 2006). The 
DD-containing protein, TNFR-associated death domain (TRADD), associates with IPS-1, 
TRAF3, TANK as well as FADD and RIP1 to activate both IRF3 and NF-κB pathways 
(Michallet et al., 2008).  
Double-stranded RNA dependent protein kinase (PKR) 
Several early observations led to the discovery of double-stranded RNA 
dependent protein kinase (PKR). IFN-treated cells infected with vaccinia virus (VV), 
which produces dsRNA, have a translational block of viral and cellular mRNAs (Colby & 
Duesberg, 1969; Friedman et al., 1972; Metz & Esteban, 1972). Also, dsRNA were 
known to inhibit protein synthesis in cells and cell-free systems (Cordell-Stewart & 
Taylor, 1973; Ehrenfeld & Hunt, 1971). Later, it was found that a dsRNA-dependent 
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kinase could inhibit the translation of mRNA by phosphorylating the alpha subunit of 
eukaryotic initiation factor 2 (eIF2α) (Farrell, Balkow, Hunt, Jackson, & Trachsel, 1977). 
This kinase was found to phosphorylate not only eIF2α but also the kinase itself (Krust, 
Galabru, & Hovanessian, 1984; Laurent, Krust, Galabru, Svab, & Hovanessian, 1985). 
Finally, the kinase was cloned and termed PKR (Clemens et al., 1993; Meurs et al., 
1990).  
 PKR is a serine/threonine kinase having the kinase domain shared with other 
eIF2α kinases and two dsRNA binding domains regulating its activity. In non-stressed 
cells, PKR is kept in a monomeric inactive state due to the inhibitory effects of the 
dsRNA binding domains. Double-stranded RNA, as the main stimulator of PKR, binds 
the dsRNA binding motifs, resulting in PKR activation and autophosphorylation 
(Clemens, 1997). PKR autophosphorylation represents its activation and leads to 
phosphorylation of eIF2α (Galabru & Hovanessian, 1987; Hovanessian, 1989). To 
effectively activate PKR, dsRNA should be longer than 30bp, correlating with the 
structure of dsRNA binding domains of PKR (Manche, Green, Schmedt, & Mathews, 
1992). In addition to dsRNA, PKR can be activated by polyanions as heparin, dextran 
sulfate, chondroitin sulfate, and poly-L-glutamine (Hovanessian & Galabru, 1987).  
 After binding dsRNA, PKR undergoes a series of conformational changes and 
homodimerization, which are important for its activation and autophosphorylation (Dey 
et al., 2005). Autophosphorylation on several residues as Thr446 and Thr451 further 
stabilizes dimer formation (Dey et al., 2005; Taylor et al., 1996; Zhang et al., 2001).  
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 Double-stranded RNA has long been shown to activate NF-κB activity 
(Visvanathan & Goodbourn, 1989). Down-regulation of PKR expression impairs NF-κB 
activation in response to dsRNA (Maran et al., 1994). PKR knockout MEF exhibits 
impaired activation of NF-κB and the induction of IFN under polyIC treatment (Yang et 
al., 1995). IKKγ/NEMO, a component in IKK complex that promotes degradation of IκB, 
is essential for PKR-induced activation of NF-κB, implying the involvement of IKK in 
the PKR-NF-κB pathway (Yamaoka et al., 1998). The involvement of IKK complex in 
PKR induced NF-κB activation in response to viral or synthesized dsRNA has been 
confirmed by several studies using the MEF lacking function of certain IKK proteins 
(Bonnet, Weil, Dam, Hovanessian, & Meurs, 2000; Chu et al., 1999; Gil, Alcamí, & 
Esteban, 2000; Zamanian-Daryoush, Mogensen, DiDonato, & Williams, 2000). These 
studies also revealed physical interaction between PKR and IKK complex (Bonnet et al., 
2000; Gil et al., 2000; Zamanian-Daryoush et al., 2000).  
 TNF receptor associated factors (TRAF) are key signal transducers in many 
pathways other than TNF receptor signaling (Chung, Park, Ye, & Wu, 2002). PKR 
possesses putative TRAF-interacting motifs, and interaction between them has been 
confirmed (Gil et al., 2004). TRAF2 and TRAF5 were found to act downstream of PKR 
and transduce signals toward NF-κB activation (Gil et al., 2004). In addition, TRAF3 was 
found to be essential for PKR-induced production of type I IFN (Oganesyan et al., 2006).  
 PKR is involved in many kinds of signaling pathways downstream of various 
growth factors and cytokines. IFNα/β/γ are transcriptional activators of PKR, while the 
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transcription of IFNγ is self-regulated by a pseudo-knot and followed by PKR activation 
(Ben-Asouli, Banai, Pel-Or, Shir, & Kaempfer, 2002). PKR also mediates IFN-γ 
triggered activation of NF-κB and c-myc expression in a STAT1 independent manner 
(Deb, Haque, Mogensen, Silverman, & Williams, 2001a; Ramana et al., 2000). In 
addition, in synergy with TNF-α, PKR activates NF-κB via affecting IKBβ stability 
downstream of IFNγ (Cheshire, Williams, & Baldwin, 1999). Inhibiting or 
down-regulating PKR results in slight but sustained and reproducible defects in TNF-α 
induced NF-κB activation (Kumar et al., 1997; Maran et al., 1994).  
Methods 
mESC Culture  
D3 cells, a commonly used mESC line in the literature, were obtained from ATCC. They 
were used for the majority of the experiments in this study. The key experiments were 
repeated in DBA252 mESCs previously characterized (Guo, Ye, & Huang, 2007). Both 
cell lines were maintained in the standard mESC medium (Guo et al., 2007). Raw 264.7 
(Raw) and 10T1/2 cells were cultured in DMEM that contains 10% fetal calf serum and 
100 units/ml penicillin and 100μg/ml streptomycin. All cells were maintained at 37 °C in 
a humidified incubator with 5% CO2.  
Cell treatment 
mESCs and 10T1/2 were plated at ~40% and ~70% confluence, respectively and 
cultured for 24 h before the experiments. For viral infection, viral stocks were added to 
the cell culture at the concentrations as specified in individual experiments. PolyIC (Sigma) 
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was either directly added to the cell culture or was transfected into the cells with 
DharmaFECT reagent (Thermo Scientific). For polyIC transfection experiments, control 
cells were transfected with DharmaFECT reagent only. The culture medium and treated 
cells were collected at different time periods and used for various analyses.  
Preparation of viral stocks 
La Crosse virus (LACV, stain name) and West Nile virus (WNV, stain 2471) were 
propagated in vero cells (African green monkey kidney cell line, ATCC). Titers of virus 
stocks were determined by plaque assay as previously described (22). Sendai virus (SeV, 
Cantell strain) stock was purchased from Charles River laboratory.  
Real-time quantitative polymerase chain reaction (RT-qPCR)  
RNA Extraction: Total RNA was extracted using Tri-reagent (Sigma). Medium 
was aspirated from the culture dish, and Tri-reagent was added followed by 3 minutes of 
shaking. The sample was transferred to a 1.5 mL microcentrifuge tube and stored at 
-70°C. Chloroform (0.2 mL per mL of Tri-reagent) was added. Samples were then 
vortexed for 15 seconds and incubated at room temperature for 10 minutes. Next, 
samples were centrifuged at 10000 rpm for 10 minutes at 4°C. The aqueous supernatant 
containing RNA was transferred to a new 1.5 mL microcentrifuge tube, and an equal 
volume of isopropyl alcohol was added. After a 10 minute incubation at room 
temperature, samples were centrifuged at 12000 rpm for 15 minutes at 4°C to precipitate 
a pellet of RNA. The supernatant was aspirated, and samples were washed with 0.7 mL 
cold 75% ethanol, vortexed, and placed in -20°C for at least one hour. Samples were then 
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centrifuged at 10000 rpm for 10 minutes at 4°C, ethanol was removed, and RNA pellets 
were allowed to dry for 5 minutes on ice. Finally, RNA was dissolved in 20 uL 
DEPC-water, RNA concentration was measured by a Spectronic Genesys 10 Bio 
spectrophotometer, and RNA integrity was checked by agarose gel electrophoresis. 
Reverse Transcription: For each sample, 1 μg of RNA was mixed with dNTPs 
and a random primer, mixed, and held at 70°C in a thermal cycler for 5 minutes to melt 
secondary structure within the RNA template. Then a 5x buffer (Fisher), M-MLV reverse 
transcriptase (Fisher), and RNase inhibitor (Fisher) were added for a total volume of 20 
μL per reaction, and samples were held at 42°C for a 1 hour extension step, followed by 
10 minutes at 95°C to inactivate the reverse transcriptase enzyme. Resulting cDNA was 
diluted in 200 μL DEPC-water. 
Real-time quantitative polymerase chain reaction (RT-qPCR): Total RNA was 
extracted using Tri-reagent (Sigma). cDNA was prepared by M-MLV reverse 
transcriptase (Sigma). RT-qPCR was performed using SYBR green ready mix on a 
MX3000PTM RT-PCR system (Stratagene), as previously reported (Guo et al., 2007). 
The mRNA level from RT-qPCR was calculated using the comparative Ct method (Pfaffl, 
2001). -actin mRNA was used as a calibrator for the calculation of relative mRNA of 
the tested genes. The sequences of the primer sets are listed in Table 1.  
Table 1 
Primer sequences for RT-qPCR  
Gene Sequence (forward) Sequence (reverse) 
β-actin CATGTACGTAGCCATCCAGGC CTCTTTGATGTCACGCACGAT 
IFNa  CTGCTGGCTGTGAGGACATA AGGAAGAGAGGGCTCTCCAG 
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Table 1 (continued). 
Gene Sequence (forward) Sequence (reverse) 
IFNβ CCCTATGGAGATGACGGAGA ACCCAGTGCTGGAGAAATTG 
IL-1α TCTATGATGCAAGCTATGGCTCA CGGCTCTCCTTGAAGGTGA 
IL6 TAGTCCTTCCTACCCCAATTTCC TTGGTCCTTAGCCACTCCTTC 
TNF-α CAGGCGGTGCCTATGTCTC CGATCACCCCGAAGTTCAGTAG 
ICAM1 GGCATTGTTCTCTAATGTCTCCG GCTCCAGGTATATCCGAGCTTC 
VCAM CCAAATCCACGCTTGTGTTGA GGAATGAGTAGACCTCCACCT 
TLR3 CTTGCGTTGCGAAGTGAAGAA CCAATTGTCTGGAAACACCCC 
RIG-I ATTCAGGAAGAGCCAGAGTGTC GTCTTCAATGATGTGCTGCAC 
PKR AAGCAGGAGGCAAGAAACG TGACAATCCACCTTGTTTTCGT 
MDA5 CGATCCGAATGATTGATGCA AGTTGGTCATTGCAACTGCT 
Flk1 GCAAAACACTCACCATTCCCA GAGGTTTGAAATCGACCCTCG 
Erg ACCTCACCCCTCAGTCCAAA TGGTCGGTCCCAGGATCTG 
Fli1 ATGGACGGGACTATTAAGGAGG GAAGCAGTCATATCTGCCTTGG 
GATA2 CACCCCGCCGTATTGAATG CCTGCGAGTCGAGATGGTTG 
VE-cad ATGAATCGCTGCCCCACTATG CATTCCCTGTGTTAGCATCGAC 
PECAM1 TGCACCCATCACTTACCACC CTTCATCCACCGGGGCTATC 
Oct-4 AGTTGGCGTGGAGACTTTGC CAGGGCTTTCATGTCCTGG 
Nanog TTGCTTACAAGGGTCTGCTACT ACTGGTAGAAGAATCAGGGTC 
Sox-2 GACAGCTACGCGCACATGA GGTGCATCGGTTGCATCTG 
Klf4 GGCGAGTCTGACATGGCTG GCTGGACGCAGTGTCTTCTC 
Rex-1 TGGAAGCGAGTTCCCTTCTC GCCGCCTGCAAGTAATGAG 
GATA4 CCCTACCCAGCCTACATGG ACATATCGAGATTGGGGTGTCT 
GATA6 TTGCTCCGGTAACAGCAGTG GTGGTCGCTTGTGTAGAAGGA 
Brachyury CAGCCCACCTACTGGCTCTA GAGCCTCGAAAGAACTGAGC 
Cdx2 CACCATCAGGAGGAAAAGTGA CTGCGGTTCTGAAACCAAAT 
FGF5 GCTGTGTCTCAGGGGATTGT ACAGTCATCCGTAAATTTGGC 
ISG15 AGGTCTTTCTGACGCAGACTG GGGGCTTTAGGCCATACTCC 
OAS1a GCCTGATCCCAGAATCTATGC GAGCAACTCTAGGGCGTACTG 
IFNAR1 GACAACTACACCCTAAAGTGGAG GCTCTGACACGAAACTGTGTTTT 
IFNAR2 TGTCTGCGAGCCTAGAGACTA AGCCGGGAATTTCGTATTGTTAT 
STAT1 GCTGCCTATGATGTCTCGTTT TGCTTTTCCGTATGTTGTGCT 
STAT2 CTGAAGGACGAACAGGATGTC CAGGGTGGTTAATCGGCCAA 
JAK1 ACGCTCCGAACCGAATCATC GTGCCAGTTGGTAAAGTAGAACC 
TYK2 TGCATCCACATCGCACACAA CTCCTGGGGATTCATGCCA 
IRF9 TGTCTGGAAGACTCGCCTAC GCAACATCCATACGACCTCTCT 
SOCS1 CTGCGGCTTCTATTGGGGAC AAAAGGCAGTCGAAGGTCTCG 
Note. Sequences of all primers are listed from 5’-end to 3’-end. 
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IFNβ and cytokine assays  
The culture medium collected from treated cells was used to determine secreted 
IFNβ and cytokines. IFNβ was quantified with an ELISA kit that detects mouse IFNβ 
(PBL Biomedical Laboratories) according to the manufacturer’s instruction. IL6 and 
TNFα were analyzed with a Luminex cytokine assay kit (Millipore) and determined with 
a MAGPIX instrument. The data were analyzed according to the method described by 
Prabhakar et al. (Prabhakar, Eirikis, & Davis, 2002).  
Cell proliferation, viability, and cell cycle analysis  
Cell proliferation was determined by colony size and by cell number after 
toluidine blue (TB) staining as previously described (Guo, Chakraborty, Rajan, Wang, & 
Huang, 2010). The absorbance at 630 nm of TB stained cells was measured with a 
microtiter plate reader. The values, which correlate with the number of viable cells, were 
used as an indirect measurement of cell proliferation or viability. Cell cycle analysis by 
flow cytometry was performed after the cells were stained with 50 µg/ml propidium 
iodide. The cell cycle profiles were generated with the CFlow software. 
Protein analysis by flow cytometry  
Cellular protein analysis by flow cytometry was performed according to our 
published method (Wang & Guo, 2012). Briefly, treated cells were incubated with the 
antibodies against the specific proteins to be analyzed. The cells were then incubated with 
secondary antibodies conjugated with FITC (fluorescein isothiocyanate) and examined by 
an Accuri C6 flow cytometer. The fluorescence intensity, which correlates with the 
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protein level, was determined with the CFlow software. In some experiments, cells were 
doubly stained with propidium iodide, so the expression level of the protein in different 
phases of the cell cycle could be simultaneously determined.  
siRNA transfection  
siRNAs targeting PKR and RIG-I or negative control siRNAs (Santa Cruz 
Biotechnology) were transfected to mESCs with a DharmaFECT reagent at a final 
concentration of 100 nM. The cells were then analyzed for siRNA knockdown efficiency 
or used for the experiments as specified.  
Cell lysate preparation and Western blot analysis  
Cells were directly lysed with a SDS sample buffer that contained 150 mM NaCl, 
10 mM NaF, and 0.25 mM NaVO4. Western blot analysis was carried out as previously 
described (Guo et al., 2010).  
Immunostaining assay  
Treated cells were fixed with 4% paraformaldehyde for 15 min at room 
temperature. Cells were washed with PBS containing 0.3% hydrogen peroxide to block 
endogenous peroxidase activity for 30 min. Cells were blocked with 2% normal goat 
serum with 0.4% Triton-X100 and incubated primary antibodies overnight at 4˚. The 
cells were washed with PBS and then incubated with secondary antibodies conjugated 
with HRP (horseradish peroxidase) for 2 h at room temperature. Positive cells were 
detected using a TrueBlue detecting kit (KPL) under a phase contrast microscope. 
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Statistical analysis  
Data were presented as the mean + SD derived either from three independent 
experiments or from a representative experiment performed in triplicates that were 
performed at least twice with similar results. Statistical analysis was performed using a 
2-tailed and paired student’s t-test. Differences are considered statistically significant 
when P < 0.05. 
Results 
mESCs are Susceptible to the Cytopathic Effects of LACV Infection 
To investigate the responses of mESCs to viral infection, The author first infected 
cells with LACV (a negative sense ssRNA virus) that is known to cause lytic cell death of 
mammalian cells (Verbruggen et al., 2011). 10T1/2 cells, a mouse cell line with 
fibroblast properties (Haas & Tuan, 2000), were used as a positive control. Following the 
infection with LACV (MOI=1), cytopathic effects were observed at 48 h post infection in 
10T1/2 cells. These effects included cell morphological changes such as rounding up and 
detachment from the culture dish. Similar effects were observed in mESCs at a longer 
incubation time (> 60 h) (Figure 5A, indicated by arrows). The viral infection of mESCs 
was confirmed by the expression of a LACV gene that encodes an M-segment protein 
(Gc protein) (Soldan, Hollidge, Wagner, Weber, & Gonzalez-Scarano, 2010). The 
infected cells were immunostained with monoclonal antibodies against the Gc protein (a 
gift from Dr. Samantha Soldan, University of Pennsylvania School of Medicine) 
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followed by flow cytometry analysis. As shown in Figure 5B, the expression of the Gc 
protein was detected at 30 h and was significantly increased at 40 h post infection. 
The cytopathic effect of LACV was proportional to viral loading as indicated by 
the reduced number of viable cells at different MOIs (Figure 5C & D). LACV infection 
also caused cell cycle inhibition as indicated by an apparent reduction of cells in the G2 
phase (Figure 5E, indicated by arrow) and a reduced expression level of cyclin E (Figure 
5F). Therefore, the reduced cell number of mESCs by LACV infection could be due to 
the lytic cell death as well as by a general inhibition of cell proliferation associated with 
viral infection.   
 
Figure 5. Infection of mESCs and 10T1/2 cells with LACV. A, mESCs (D3), and 10T1/2 
cells were infected with LACV (MOI=1). The cells were examined under a phase 
contrast microscope and photographed (400 x) at 48 h for 10T1/2 cells and 60 h for D3 
cells. Arrows denote detaching dead cells. B, Detection of LACV Gc protein in D3 cells 
infected with LACV (MOI=10) by flow cytometry. C, D3, and 10T1/2 cells were infected 
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with LACV at MOI of 1. Viable cells were determined at 48 h post infection by toluidine 
blue cell staining. The values are means ± SD of a representative experiment performed 
in biological triplicates. D, D3 cells were infected with LACV at different MOI as 
indicated. Viable cells were determined at 48 h post infection as described in C. E, D3 
cells were infected with LACV (MOI=10). The cell cycle profiles and cell count were 
determined with CFlow software. Reduction of the G2 phase cells was indicated by the 
arrow. F, Cyclin E expression level in LACV infected D3 cells described in E (40 h) was 
determined by flow cytometry. The control (Con) represents cells without viral infection. 
All experiments were performed at least twice with similar results. 
mESCs are Deficient in Expressing Type I IFNin Response to Viral Infection  
Under normal conditions, very low mRNA levels of IFNα and IFNβ were 
detected in 10T1/2 cells and were nearly undetectable in mESCs. LACV infection 
induced about 1900-fold increase of IFNβ in 10T1/2 at MOI of 1, but the induction in 
mESCs was negligible even at MOI of 10 (Figure 6A). In addition, LACV infection 
upregulated the expression of IFNβ and the major viral RNA receptors, including RIG-I, 
PKR, MDA5, and TLR3, to different degrees in 10T1/2 cells, but such effects were not 
observed in mESCs (Figure 6A). These results indicated that mESCs are susceptible to 
LACV infection, but they are unable to effectively express IFNα and IFNβ. 
To determine if this observation is a general property of mESC or if it is an event 
specific to LACV infection, two additional viruses, WNV (a positive sense ssRNA virus) 
and SeV (a negative sense ssRNA virus), were tested. In both cases, viral infection 
induced a large increase of IFN transcription in 10T1/2 cells, but the induction in 
mESCs was less than 5 fold (Figure 6B & C).  
Viral infectivity in both mESCs and 10T1/2 cells was confirmed by the expression 
of viral proteins. The E glycoprotein encoded by WNV (Hanna et al., 2005) was detected 
with its monoclonal antibodies (4G2, ATCC) by immunostaining (Figure 6B, inset), while 
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the nucleocapsid protein (NP) encoded by SeV (Ye & Maniatis, 2011) was detected by 
RT-PCR analysis (Figure 6C, inset).  
 
Figure 6. Viral infection induced expression of IFN and IFN in D3 and 10T1/2 cells. A, 
10T1/2 and D3 cells were infected with LACV at MOI of 1 and 10, respectively. The 
mRNA levels of the tested genes were determined by RT-qPCR 24 h post infection. B, 
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10T1/2 and D3 cells were infected with WNV at MOI of 5 and 10, respectively. The 
mRNA levels of IFN and IFN were determined by RT-qPCR 24 h post infection 
(graph). The infected cells were immunostained with antibodies against a WNV E 
glycoprotein. The positive cells were detected as dark cells (inset). C, 10T1/2 and D3 
cells were infected with SeV at 300 HAU/ml. The mRNA levels of IFN were 
determined by RT-qPCR 12 h and 24 h post infection (graph). The transcription of SeV 
NP protein in infected cells was determined by RT-PCR and analyzed by agarose gel 
electrophoresis (inset). All results shown in the graphs are expressed as fold-activation 
where the mRNA level in control cells is designated as 1 (not shown). The values are 
means ± SD of three independent experiments. The experiments shown in insets were 
performed twice with similar results. 
Although a slight but consistent inhibition of cell proliferation was noted in the 
infected cells with WNV and SeV (data not shown), WNV and SeV did not cause 
apparent lytic cell death as LACV.  
mESCs Can Sense and Respond to dsRNA via Cytosolic Receptors, but Fail to Produce 
Functional IFN and IL6 
The author further analyzed the responses of mESCs to polyIC, a synthetic analog 
of viral dsRNA that is widely used to mimic viral infection. When directly added to the 
cell culture, polyIC is expected to bind to TLR3 at the cell surface or to be internalized 
into the endosomes where it activates TLR3 (Matsumoto et al., 2003; Vercammen, Staal, 
& Beyaert, 2008). This phenomenon was demonstrated in Raw cells where polyIC 
induced the expression of IFNand IFN but not in mESCs (data not shown), indicating 
that mESCs may not have functional TLR3 and/or a functional mechanism for polyIC 
internalization. However, when transfected into the cells, polyIC can induce several-fold 
increase of the transcription of three types of molecules typically seen in antiviral 
responses: type I IFN (IFN/), inflammatory cytokines (TNF, IL1), and the cell 
adhesion molecule (VCAM1) in D3 mESCs (Figure 7A). Similar results were obtained in 
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another line of mESCs, DBA252 (Figure 7B). These results imply that mESCs can sense 
and respond to dsRNA via cytoplasmic receptors.  
 
Figure 7. PolyIC transfected to mESCs can induce low level transcription of immune 
mediators but fail to produce detectable proteins. A, B, and C, D3, DBA252, and 10T1/2 
were transfected with 300 ng/ml polyIC. mRNA was analyzed by RT-qPCR. The results 
are expressed as fold-activation where the mRNA level in control cells is designated as 1. 
The values in A and C are means ± SD of three independent experiments. The values in B 
are means ± SD of a representative experiment performed in biological triplicates. D, D3, 
and 10T1/2 were transfected with polyIC as described in A and C. For Raw cells, polyIC 
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(25 g/ml) was directly added to the culture medium. The culture medium collected at 
different time points was analyzed for IFNby ELISA (detectable range 15.6-1000 
pg/ml) and IL6 by Luminex assay (detectable range 0.64-10000 pg/ml). ND, not detected. 
The values for IFNare means ± SD of a representative experiment performed in 
triplicate. The values for IL6 are average of a representative experiment performed in 
duplicate. E, Expression profiles of ICAM1 in 10T1/2 and in D3 cells determined by 
flow cytometry. The representative experiments in all panels were repeated at least twice 
with similar results.  
However, the induction of IFN in mESCs was negligible when compared with 
10T1/2 cells, whereby polyIC-induced nearly a 4000-fold increase of IFN mRNA. 
PolyIC-induced transcription of IL6 and ICAM1 was also substantially higher in 10T1/2 
cells than in mESCs (Figure 7C). When examined at the protein level by ELISA, neither 
IFN nor IL6 was detected in the media collected from polyIC-transfected mESCs, 
whereas they were readily detected in the samples from Raw cell and 10T1/2 cell cultures 
(Figure 7D).  
Similar results were obtained for TNF (data not shown). Similarly, ICAM1 
protein was induced by polyIC transfection in 10T1/2 cells, but not in mESCs, as 
analyzed by flow cytometry of the cells immunostained with anti-ICAM1 antibodies 
(Santa Cruz) (Figure 7E). Therefore, transfected polyIC could elicit a limited increase of 
transcripts of the above mentioned immune mediators in mESCs, but their corresponding 
proteins were not detected.  
PolyIC-transfected to mESCs Inhibits Cell Proliferation  
The most notable effect of transfected polyIC on mESCs at the cellular level was 
the inhibition of cell proliferation. As shown in Figure 8, the colonies of 
polyIC-transfected cells were much smaller than the control colonies (Figure 8A), 
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correlating with markedly reduced cell numbers (Figure 8B). In control cells, about 60% 
of cells were in the S phase, but polyIC caused an apparent reduction of cells in the S and 
G2/M phases (Figure 8C, indicated by arrow and arrowhead, respectively). A time course 
analysis revealed that the effects of polyIC can be detected as early as 6 h (Figure 8D). It 
is noted that the polyIC transfection also caused a small number of apoptotic cells 
(floating cells, data not shown), which may also contribute to the reduced cell number 
and colony size.   
 
Figure 8. Effects of polyIC on mESC colony formation and cell proliferation. A-C, D3 
cells were transfected with 300 ng/ml polyIC. Control (Con) represents cells transfected 
with DharmaFECT without polyIC. A, After incubation for 40 h, the colonies were 
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examined under a phase contrast microscope and photographed with a digital camera 
(100 x, upper panels; 400 x, lower panels). B, Cell proliferation was measured by cell 
number indirectly determined from toluidine blue staining (absorbance at 630 nm). The 
values are means ± SD of an experiment performed in biological triplicate. C, Cell cycle 
was analyzed by flow cytometry. The cell cycle profiles and cell count were determined 
with a computer software. Reduction of the S and G2/M phase cells were indicated by 
the arrow and arrowhead, respectively. D, D3 cells were transfected with polyIC and 
incubated for the times as indicated. The cell cycle progression was analyzed by flow 
cytometry as described in C. E, The effect of polyIC on cyclin E expression was 
determined by flow cytometry after immunostaining of the cells with antibodies against 
cyclin E. All representative experiments were performed at least twice with similar 
results. 
Since the constitutive activation of Cdk2 by cyclin A and E is the key factor that 
drives the rapid cell proliferation in mESCs (Stead et al., 2002), the effects of polyIC on 
the expression of these cell cycle regulators were examined.  
The reduced expression of cyclin E was apparent at 6 h after treatment, and this 
trend lasted for 24 h, as determined with its antibodies (Santa Cruz) by flow cytometry 
(Figure 8E). Although cyclin A was not affected at 6 h and 12 h, it was reduced at 24 h. A 
similar pattern was seen for Cdk1 and Cdk2. The CdkIs, p16, p19, and p21, were 
expressed at very low levels in control cells, and polyIC did not affect their expression 
(data not shown). These results suggest that down-regulation of cyclin E, and to a lesser 
extent, cyclin A, Cdk1, and Cdk2, contributed to polyIC-inhibited cell proliferation. 
The Effect of polyIC on the Stem Cell State  
To test if the stem cell state of mESCs was affected by polyIC, I examined the 
mRNA levels of pluripotency markers in polyIC-transfected cells. They were transiently 
down-regulated at 6 h and 12 h, but recovered nearly to the level of the controls by 24 h 
(Figure 9A).  
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In agreement with mRNA change, the protein level of Oct4, a key gene in the 
pluripotency control network (Niwa, 2007), displayed a similar pattern with an initial 
slight decrease, but returned to the normal levels at 24 h (Figure 9B).  
 
Figure 9. Effects of polyIC on the expression of pluripotency/differentiation markers and 
cell/colony morphology of mESCs. D3 cells were transfected with 300 ng/ml polyIC and 
incubated for a time course of 24 h. A and C, The mRNA levels of pluripotency markers 
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and early differentiation markers were determined by RT-qPCR. The results are means ± 
SD of three independent experiments. B, The effect of polyIC on the protein level of Oct 
4 was determined by flow cytometry. -1st AB represents the experiments where the cells 
were not incubated with anti-Oct4 antibodies (1st antibodies) as the control. D. The effect 
of polyIC on cell/colony morphology was examined under a phase contrast microscope 
and photographed with a digital camera at 72 h after treatment (400x). The images are 
representative experiments performed at least three times. 
Interestingly, the transcription of several early differentiation markers showed a 
similar dynamic pattern (Figure 9C) to the pluripotency markers (Figure 9A).  
Due to polyIC-induced cell cycle inhibition, the colonies formed from 
polyIC-transfected cells were smaller than those formed from control cells, but their 
overall morphology (round with densely packed undifferentiated cells) was not 
significantly changed, as examined at 40 h (as shown in Figure 9A) or at 72 h post 
transfection (Figure 9D). 
The Relative Expression Levels of dsRNA Receptors in mESCs and 10T1/2 cells   
 
Figure 10. Relative mRNA levels of dsRNA receptors in mESCs and 10T1/2 cells. The 
mRNA levels of dsRNA receptors in D3 (A), DBA252 (B), and 10T1/2 (C) were 
determined by RT-qPCR. Their relative abundance in each cell was determined by 
comparing with the mRNA level of -actin (designated as 1). For a direct comparison, 
the relative mRNA level of each molecule in D3 cells and 10T1/2 cells was presented in 
panel C. The results are means ± SD of three independent experiments in all panels. 
To identify the receptor(s) that mediate the effects of transfected polyIC, the 
relative expression levels of the four dsRNA receptors was analyzed. The mRNA level of 
each molecule was determined by RT-qPCR and compared with that of β-actin. In D3 
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cells, TLR3 is expressed at a very low level, and MDA5 is barely detected, while RIG-I 
and PKR are expressed at higher levels (Figure 10A). A similar pattern was seen in 
DBA252 cells (Figure 10B). When compared with 10T1/2 cells, the mRNA of TLR3 and 
MDA5 in D3 cells are negligible, while RIG-I is about one third of that in 10T1/2 cells. 
However, PKR is expressed at similar levels in the two types of cells (Figure 10C).  
PKR Plays a Key Role in Mediating the Effects of polyIC in mESCs  
The higher basal expression levels of PKR and RIG-I in mESCs make them the 
likely candidates that mediate the effects of polyIC. The author first investigated PKR by 
its ability to phosphorylate eukaryotic initiation factor 2α (eIF2α). It is known that 
phosphorylation of eIF2αby PKR attenuates its function in translation, thereby resulting 
in protein synthesis inhibition (Garcia, Meurs, & Esteban, 2007). PolyIC indeed 
stimulated eIF2α phosphorylation in mESCs as determined by flow cytometry and 
confirmed by Western blot analysis using antibodies that specifically recognize 
phosphorylated eIF2α (p-eIF2α Cell Signaling) whereas, the expression of PKR did not 
change significantly. p-eIF2α was detected as early as 30 min after polyIC transfection 
(Figure 11A, boxed areas), which preceded cell cycle inhibition. Pretreatment of the cells 
with a PKR inhibitor C16 (Sigma) blocked polyIC-induced eIF2α phosphorylation, 
indicating that PKR is the responsible kinase. These results were confirmed with siRNA 
targeting PKR, which attenuated eIF2α phosphorylation while the negative control 
siRNA had no effect (Figure 11B, upper panels, boxed areas). Importantly, silencing 
PKR reversed polyIC-induced reduction of S and G2/M phase cells (Figure 11B, middle 
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panels) as well as reduced colony size (Figure 11B, lower panels). On the other hand, 
knocking down RIG-I did not show such effects. These data demonstrate that PKR, not 
RIG-I, plays a key role in mediating polyIC-induced cell cycle inhibition.  
 
Figure 11. PKR plays key roles in mediating the effects of polyIC. A, PolyIC-induced 
phosphorylation of eIF2D3 cells were transfected with 300 ng/ml polyIC and 
incubated for times indicated. The cells with phosphorylated eIF2 (p-eIF2 were 
quantified by flow cytometry (boxed areas. White slash lines were used to help identify 
the bottom sides of the boxes). The blot insets illustrate the levels of p-eIF2 and PKR 
determined by Western blot. Actin was used as a loading control. B, The effects of PKR 
and RIG-I silencing on polyIC-induced cellular events. D3 cells were transfected with 
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siRNA against PKR (siPKR), RIG-I (siRIG-I), or negative control siRNA (siNeg) for 24 
h. The cells were split into new dishes. After 24 h, the cells were transfected with polyIC 
for 24 h and analyzed for p-eIF2 by flow cytometry (upper panels), cell cycle by flow 
cytometry (middle panels, the changes in S and G2/M phase cells were indicated by the 
arrow and arrowhead, respectively), and cell proliferation/colony formation by 
microscopy (lower panels). C and D, Relative contributions of PKR and RIG-I to 
polyIC-induced mRNA of IL6 and IFN. D3 cells were transfected with siPKR, siRIG-I, 
or siNeg followed by polyIC treatment as described in B. The mRNA levels of PKR and 
RIG-I (C) or IL6 and IFN(D)were determined by RT-qPCR and compared with the 
mRNA in the cells that were transfected with siNeg (defined as 1) in each group. The 
results are means ± SD of three independent experiments. The difference is considered to 
be statistically significant when p<0.05 (*). All representative experiments in A and B 
were performed at least twice with similar results. 
The effects of silencing PKR and RIG-I on polyIC-induced transcription of IFNβ 
and IL6 were then analyzed. siRNA targeting PKR and RIG-I specifically knocked down 
their targets as expected (Figure 11C). Silencing PKR significantly reduced mRNA levels 
of both IL6 and IFNβ while silencing RIG-I slightly attenuated transcription of IL6, but 
not that of IFNβ (Figure 11D).  
PKR is Activated by LACV, but not by WNV or SeV Infection in mESCs 
Whether or not PKR was activated in viral infected cells was analyzed. As shown 
in Figure 12A, a time course study of LACV-infected cells indicated PKR was activated 
at 11 h post infection and lasted up to 30 h as indicated by eIF2α phosphorylation, while 
the protein level of PKR was not altered as determined by Western blot with PKR 
antibodies (Santa Cruz).  
Knocking down PKR expression did not have an apparent effect on 
LACV-induced cell death (Figure 12B). Similar results were obtained in the experiments 
with C16 PKR inhibitor (data not shown). PKR activation by LACV was further 
confirmed by flow cytometry with antibodies against p-eIF2α; however, p-eIF2α was not 
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detected in the cells infected with WNV or SeV in parallel experiments (Figure 12C). 
These results suggested that PKR activation is virus-dependent in mESCs. 
 
Figure 12. Effects of viral infections on PKR activation. A, Activation of PKR by LACV 
infection in mESCs. D3 cells were infected with LACV (MOI=10) for the different time 
periods as indicated. Activation of PKR was analyzed by Western blot with antibodies 
against p-eIF2αActin was used as a control for protein loading. B, Silencing PKR did not 
have an apparent effect on LACV-induced cell death. D3 cells were transfected with 
siRNA against PKR (siPKR) or control siRNA (siNeg) as described in Figure 7C. The 
efficiency and specificity of PKR knockdown were analyzed by Western blot (blot inset) 
after 36 h transfection. Con represents the cells without transfection. The cells, either 
transfected with siRNA (siNeg or siPKR) or without (Con), were infected with LACV at 
MOI of 10. The cell viability was determined at 48 h post infection as described in Figure 1. 
C, WNV and Sev infection did not activate PKR in mESCs. D3 cells were infected with 
WNV (MOI=10) or SeV (300 HAU/ml) for the specified times. The cells with 
p-eIF2αwere quantified by flow cytometry (boxed areas. White slash lines were used to 
help identify the bottom sides of the boxes). Cells infected with LACV (MOI=10) were 
used as a positive control for comparison. The values shown in the graph (B) are means ± 
SD of three independent experiments. The results in all other panels are representatives of 
experiments performed at least twice with similar results. 
Discussion 
In the first project, the responses of mESC to three types of live viruses and two 
synthetic viral dsRNA analogs were investigated. While all of these stimuli induced a 
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robust IFN/ expression in 10T1/2 cells, they only induced very limited or no 
detectable transcription of IFN/. These results suggest that mESCs are deficient in 
type I IFN expression, a central component of the antiviral mechanisms in most types of 
somatic cells. 
It is known that many viruses have developed certain mechanisms to avoid the 
host antiviral responses (Haller, Kochs, & Weber, 2006). Repressing IFNα/β induction in 
host cells is one of such mechanisms that have been reported for LACV and SeV (Haller 
et al., 2006; Ye & Maniatis, 2011). However, the capacity of these viruses to repress 
IFNα/β induction seems to depend on the types of host cells, as demonstrated in 10T1/2 
cells in which LACV can induce strong transcription of IFNα/β as well as the key 
components involved in IFNα/β expression, such as RIG-I, MDA5 and TLR3. The 
induction of IFNβ by WNV and SeV in 10T1/2 cells was also significant. Therefore, the 
failure to express IFNα/β in mESCs is not virus-specific or due to the viral anti-IFN 
induction mechanism. This conclusion is in line with the observations recently reported 
by Wash et al. (Wash et al., 2012) that herpes simplex virus type I (HSV-1, a DNA virus) 
and influenza virus exert (a negative sense ssRNA virus) cytopathic effects without 
evoking type I IFN induction. Together with results from the experiments with polyIC 
and 3p-ssRNA (see CHAPTER IV ), which mimic viral RNA in inducing a robust 
IFNα/β expression in 10T1/2 cells but not in mESCs, it can be concluded that deficiency 
in type I IFN expression is an intrinsic property of mESCs. 
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This study provided the molecular basis that explains the defective IFNα/β 
expression in mESCs. In some cell types, polyIC can induce IFNα/β via activation of 
TLR3 at the cell surface or in the endosomes (Meylan & Tschopp, 2006; Nasirudeen et 
al., 2011; Stetson & Medzhitov, 2006). When transfected into the cells, polyIC can 
induce robust IFNα/β expression and other responses that are similar to those evoked by 
viral infection via cytoplasmic dsRNA receptors (Fortier et al., 2004; Matsumoto & Seya, 
2008). mESCs were unresponsive to polyIC that was directly added to the medium, 
likely due to the very low level expression of TLR3. However, polyIC transfected into 
the mESCs showed a profound inhibitory effect on proliferation, a known effect of 
polyIC on many types of differentiated cells, indicating that the cytoplasmic receptors for 
polyIC are active in mESCs.  
One of the distinctive features of mESCs is their rapid cell proliferation that is 
driven by constitutively active Cdk2/cyclin A/E complexes (Burdon et al., 1999; Singh & 
Dalton, 2009). It is conceivable that actively dividing mESCs are more sensitive to 
polyIC-inhibited translation since cell proliferation critically depends on de novo protein 
synthesis. PolyIC inhibited cell proliferation was expected to significantly affect the stem 
cell state. However, the morphology of the individual cells and colonies appeared to be 
maintained at the undifferentiated state despite their transient decrease in transcription of 
pluripotency markers. Since polyIC caused similar changes to the transcription of 
differentiation markers, the effect is not gene specific, but rather a general transcription 
disturbance similar to that caused by viral infection (Garcia et al., 2007). It is speculated 
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that the non-specific transcription interference might help mESCs maintain their stem 
cell state by preventing the expression of genes that promote differentiation, at least for a 
short period of time under our experimental conditions. PolyIC-induced cell cycle 
inhibition is transient since polyIC-treated cells can resume a normal rate of proliferation 
in the subculture when they were passed to new culture dishes. Thus, the transient change 
of pluripotency and differentiation markers is not surprising since the experiments were 
performed in the presence of leukemia inhibitory factor (LIF), which maintains the 
pluripotency and prevents differentiation of mESCs. This observation is in line with the 
author’s recent study demonstrating that the transient inhibition of cell proliferation does 
not compromise the stem cell state of mESCs (Wang & Guo, 2012). 
   It is generally believed that MDA5 and RIG-I play primary roles in mediating 
viral RNA induced IFNα/β expression in the cytoplasm (Nasirudeen et al., 2011; Stetson 
& Medzhitov, 2006) while PKR also contributes to and modulates this process (Garcia et 
al., 2007; Samuel, 2001). Since MDA5 is expressed at negligible level in mESCs, it is 
conceivable that PKR and/or RIG-I may mediate the effects of transfected polyIC. 
However, the RIG-I signaling pathway seems to be inactive since silencing RIG-I did not 
affect the effects of polyIC and that 3p-ssRNA (5'-triphosphate single- stranded RNA), the 
best studied ligands of RIG-I (Pichlmair et al., 2006; Yoneyama & Fujita, 2007), failed to 
induce IFNβ in mESCs (see Chapter IV ). On the other hand, substantial evidence 
indicates that PKR plays a key role in mediating the effects of polyIC, as demonstrated by 
the phosphorylation of elF2α and the results observed in the PKR silencing experiments. 
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It is known that IFN-induced activation of ribonuclease L (RNase L) can hydrolyze both 
cellular and viral RNA (Samuel, 2001). Although polyIC could lead to RNase L activation 
in some cells, this does not seem to be the case in mESCs since polyIC did not cause rRNA 
degradation (data not shown), which is a commonly used indication of RNase L 
activation (Castelli et al., 1997). The result further supports the conclusion that polyIC 
could not induce a sufficient level of IFNα/β in mESCs for RNase L activation.   
LACV infection also activated PKR in mESCs, similar to the finding in murine 
embryonic fibroblasts (MEFs) (Streitenfeld et al., 2003). However, silencing or inhibition 
of PKR did not significantly affect LACV-induced cell death of mESCs, which is in line 
with the observation that PKR activation has little impact on viral replication as 
demonstrated in PKR-/-MEFs (Streitenfeld et al., 2003). PKR activation has been 
implicated in apoptosis, but its roles are stimulus- and virus–dependent (Zhang & Samuel, 
2007). The effects of PKR activation by LACV on mESCs could be more complex than 
polyIC due to the fact that many other cellular and viral factors are involved during 
infection. Unlike LACV infection, PKR activation was not detected in the mESCs infected 
with WNV or SeV. Failure to activate PKR by these viruses has been seen in other cells. As 
recently reported in rodent cells, WNV infection does not induce PKR activation, 
possibly through a mechanism that sequesters viral dsRNA from host PKR (Elbahesh, 
Scherbik, & Brinton, 2011). In SeV, it is proposed that PKR activation is repressed by the 
C protein encoded by the virus (Takeuchi, Komatsu, Kitagawa, Sada, & Gotoh, 2008). 
Whether or not they utilize these mechanisms in mESCs remains to be investigated. 
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It is interesting to note that hESCs do not express IFNα/β even at the mRNA level 
when transfected with polyIC (Chen et al., 2010; Foldes et al., 2010). mESCs can express 
limited transcripts of IFNα/β, IL6, and ICAM1, but nonetheless could not produce 
detectable levels of their respective proteins. Thus, the transcription of these immune 
mediators in mESCs may have limited function, if any, as an antiviral mechanism. In 
speculating the physiological significance of dsRNA induced cellular events in ESCs, it is 
worthy of mentioning that in differentiated cells, dsRNA can be formed under some 
circumstances, but they are retained in the nucleus for editing and rarely exported to the 
cytoplasm (Zhang & Carmichael, 2001). However, the nuclear retention mechanism in 
ESCs is less effective. As a result, dsRNAs may be exported to the cytoplasm in ESCs 
where they activate dsRNA receptors (Chen & Carmichael, 2009). In addition, other 
types of abnormal RNAs, such as those derived from cell death or from RNA processing, 
could activate PKR (Amarante & Watanabe, 2010). In particular, PKR is considered to be 
a “sentinel kinase for stress” for its involvement in stress response in addition to antiviral 
response (Williams, 1999, p. 6112). Therefore, it appears that dsRNA-induced inhibition 
of translation and cell proliferation in mESCs could be an important mechanism that 
helps cells deal with immunogenic stresses. 
In summary, the data demonstrate that the expression of type I IFN as a crucial part 
of antiviral responses is underdeveloped in mESCs. This study may open up an important 
area in ESC research for understanding the development of antiviral mechanisms during 
embryogenesis and how the stress from immunogenic signals affects ESC physiology. 
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CHAPTER IV 
MOUSE EMBRYONIC STEM CELLS HAVE UNDERDEVELOPED ANTIVIRAL 
MECHANISMS THAT CAN BE EXPLOITED FOR THE DEVELOPMENT OF 
mRNA-MEDIATED GENE EXPRESSION STRATEGY 
Introduction 
The data from the previous chapter demonstrated that mESCs do not express 
type I IFNs in response to viral infections and double-stranded RNA, but they are 
susceptible to LACV-induced lytic cell death and polyIC-induced cytotoxicity (a 
synthetic analog of viral dsRNA) (Wang et al., 2013). In this chapter, the author have 
further investigated the responses of mESCs to synthetic single-stranded RNA (ssRNA) 
and protein-encoding mRNA, which mimic viral RNA in inducing antiviral responses. 
The landmark achievement in generating induced pluripotent stem cells (iPSCs) 
has led to the new concept of cell reprogramming (Takahashi & Yamanaka, 2006), but 
the fact that viral vectors are commonly used for effective expression of reprogramming 
factors prevents the therapeutic use of the reprogrammed cells (Buganim, Faddah, & 
Jaenisch, 2013; Muller, Daley, & Williams, 2009). Extensive effort to avoid this problem 
has led to the development of several alternatives, among which mRNA-mediated gene 
expression has shown great promise due to its non-integrating nature (Daubman, 2011). 
This method directly introduces synthetic mRNA into the host cell for the expression of 
reprogramming factors, thus eliminating the need for viral or DNA vectors. The 
successful generation of RiPSCs (RNA-induced iPSCs) from fibroblasts (Angel & Yanik, 
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2010; Plews et al., 2010; Warren et al., 2010; Yakubov, Rechavi, Rozenblatt, & Givol, 
2010) has led to the belief that this strategy is the beginning of the new era of cell 
reprogramming (Daubman, 2011). This strategy could in principle be expanded to 
reprogram any type of cell as long as the genes that control the cell fate are identified. A 
major biological challenge, however, is that synthetic mRNA is detected as a viral RNA 
analog by host cells and induces strong antiviral responses resulting in interferon 
induction, protein synthesis inhibition, and reduced viability of host cells (Hornung et al., 
2006; Pichlmair et al., 2006). Synthetic mRNA must therefore be modified via a complex 
process to minimize their effects in eliciting antiviral responses (known as 
immunogenicity) (Warren et al., 2010). The lack of antiviral responses in mESCs 
prompted the author to investigate the feasibility of developing an mRNA-based gene 
expression strategy, with the expectation that mESCs would allow effective translation of 
synthetic mRNA without suffering the adverse effects associated with antiviral responses 
encountered in differentiated somatic cells.   
ESCs have attracted enormous attention in recent years for their differentiation 
potential as a cell source for regenerative medicine (Wobus & Boheler, 2005). Methods 
for the differentiation of ESCs to specific cell lineages have developed, most of which 
primarily depend on the spontaneous differentiation potential of ESCs and the influence 
of certain growth factors and/or cytokines. For example, VEGF and bFGF are commonly 
used to stimulate endothelial cell differentiation (Levenberg, Golub, Amit, 
Itskovitz-Eldor, & Langer, 2002; McCloskey, Stice, & Nerem, 2006; Yamashita et al., 
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2000). However, the efficiency of these methods is usually so low that isolating a pure 
cell population is difficult. The lack of effective differentiation methods to obtain specific 
types of cells in sufficient quality and quantity is a major challenge that limits clinical 
applications of ESC-derived cells. Cell lineage specification is mainly driven by the 
activation of cell-specific transcription factors during early embryogenesis. It is 
conceivable that the inefficient differentiation of existing methods is, at least in part, due 
to insufficient transcription activation during in vitro differentiation. A recent study 
reported that hESCs can be effectively differentiated into endothelial cells by viral 
vector-mediated expression of transcription factors that control vascular differentiation 
(Ginsberg et al., 2012), demonstrating that intervention at the transcription level can 
provide a much stronger driving force for ESC differentiation into a specific cell fate.  
In this study, mESCs were shown to be able to tolerate repeated transfection and 
effectively express synthetic mRNA with expected biological functions without the need 
for any chemical modifications of synthetic mRNA. Therefore, by exploiting the 
underdeveloped antiviral mechanisms in mESCs, the author demonstrated the feasibility 
that mRNA-mediated gene expression could be developed into novel strategies that 
manipulate gene expression in ESCs. 
Methods 
Cell culture and treatment 
ESCs (D3 cell line, ATCC) were cultured in standard mESC medium that 
contains leukemia inhibitory factor (LIF) as previously described (Wang et al., 2013). 
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Epithelial cells (SKOV3 cells, a human ovarian carcinoma cell line) and mouse 
fibroblasts (10T1/2 cell line, derived from mouse embryonic tissues that can differentiate 
into several cell lineages) were cultured in RPMI and DMEM medium, respectively, 
which contain 10% fetal calf serum and 100 units/ml penicillin and 100μg/ml 
streptomycin. All cells were maintained at 37 °C in a humidified incubator with 5% CO2 
(Darland & D'Amore, 2001; Haas & Tuan, 2000). 
   Cells were plated at 40-50% confluence and were usually cultured for 24 h 
before the experiments. Synthetic dsRNA (polyIC [polyinosinic-polycytidylic acid], 
Sigma), ssRNA, and mRNA in different formats were transfected into the cells with 
DharmaFECT reagent (Thermo Scientific) as previously described (Wang et al., 2013). 
The control cells were transfected with DharmaFECT reagent only. The cells were 
collected and used for various analyses after incubation for the times indicated in the 
individual experiments. 
In vitro synthesis and purification of short single-strand RNA (3p-ssRNA) and synthetic 
mRNA 
For preparation of short random sequenced 3p-ssRNA and HO-ssRNA, the 
dsDNA templates for in vitro transcription were prepared by the primer extension of the 
DNA oligo containing the T7 φ2.5 promoter sequence 
(5′-CGTAATACGACTTCACTATTAG) with a DNA template 
(5′-NnCTAATAGTGAGTCGTATTACG, N = random nucleotide sequence, A, G, C, T, 
n=18, 38, 58, or 78) using Taq DNA polymerase (Promega). The resulting dsDNA was 
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ethanol-precipitated and used as templates for in vitro transcription with the Ampliscribe 
T7-Flash Transcription Kit (Epicentre) to produce 5′-3p ssRNA (5′-pppAGNn, n=18, 38, 
58, or 78, the resulting RNA are termed 3p-20nt, 3p-40nt, 3p-60nt, and 3p-80nt) 
following the manufacturer’s protocol. The RNA transcripts were ethanol-precipitated 
and purified by 8% denaturing polyacrylamide gel electrophoresis (PAGE). HO-ssRNA 
was prepared by removing the 5′ triphosphate of above 3p-ssRNA with calf intestinal 
alkaline phosphatase (Takara) followed by PAGE purification. The resulting RNA are 
named as HO-20nt, HO-40nt, HO-60nt, and HO-80nt. 
For preparation of protein-encoding mRNA, the DNA template for enhanced 
green fluorescence protein (EGFP) mRNA was generated by PCR from a pEGFP-N1 
plasmid (BD Biosciences) using two primers containing sequences of 
5′-CGTAATACGACTCACTATTAGGAAGCTTCGAATTCTGCAGTCG and 
5′-TTTACGCCTTGAGATACATTGATG. The DNA template for mouse Etv2 was 
amplified by PCR from cDNA library prepared from a mouse lung endothelial cells using 
primers with the sequences of 
5′-CCGTAATACGACTCACTATTAGGAACCGTCAGAACAAGCATCC and 5′- 
TTTTGTTTTTGTTTTTTGTTTTATTGGCC. PCR was performed with Q5 
High-Fidelity DNA polymerase (New England Biolabs). The resulting dsDNA templates 
contain the T7 φ2.5 promoter for in vitro transcription, the 5′-UTR region with the Kozak 
sequence, and the open reading frame of EGFP or Etv2. In addition, EGFP has a 3′-UTR 
region. 
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Using the above EGFP DNA as the template, 3p-EGFP-mRNA (long 3p-ssRNA) 
was prepared by in vitro transcription under the same condition as the short ssRNA 
preparation described previously and was purified by an M100 Microcon membrane filter. 
To prepare functional EGFP and Etv2 mRNA, in vitro transcription from their DNA 
templates was carried out in the presence of the cap analog m7GpppA (chemically 
synthesized in our lab, unpublished) to generate 5′-capped EGFP and Etv2 mRNA 
transcripts. The purified RNA transcripts were polyadenylated by E. coli Poly(A) 
polymerase (New England Biolabs), resulting in functional mRNA, 
m7GpppA-EGFP-polyA, and m7GpppA-Etv2-polyA. 
Microscopic analysis and quantitative measurement of GFP expression 
The expression of GFP in live cells was visualized using a LSM confocal 
fluorescence microscope. To quantitatively measure the GFP expression level, the cells 
were grown in a black-walled, clear-bottom 96-Well cell culture plate (Costar) and 
analyzed with a SpectraMax® M5 Scanning Multi-Detection Microplate Reader 
(Molecular Devices) according to the manufacture’s instruction.  
 Reverse-transcription Real-time quantitative polymerase chain reaction 
(RT-qPCR), cell proliferation, viability, and cell cycle analysis, protein analysis by flow 






Characterization of Short Synthetic ssRNA-induced Sntiviral Responses in Epithelial 
Cells 
Synthetic short ssRNA and long protein-encoding mRNA prepared by in vitro 
transcription have been used as viral RNA mimics to study antiviral responses. The 
length and the 5’-triphosphate (3p) group of RNA are considered to be the most 
important factors in eliciting antiviral responses while the sequence seems to be less 
critical (Gondai, Yamaguchi, Miyano-Kurosaki, Habu, & Takaku, 2008; Schlee et al., 
2009a; Wang et al., 2010). A panel of short 3p-ssRNA of 20, 40, 60, and 80 nucleotides 
(nt) with a random sequence of A, U, C, and G were synthesized, each of which was 
detected as a single band with expected size by PAGE analysis (Figure 13A, gel inset). 
The potency of these short ssRNA in eliciting antiviral responses was first 
determined in a human ovarian epithelial carcinoma cell line (SKOV3 cells), which have 
been previously used as a model to study the immunogenicity of different types of RNA 
(Kubler et al., 2010; Kubler et al., 2011; Van et al., 2012). Using IFN expression as a 
benchmark for antiviral responses, it showed that only 3p-ssRNA with longer than 60 nt 
induced IFN while the removal of the 3p group completely abolished this effect, as 
demonstrated in the case of 3p-80nt-ssRNA (Figure 13A, 3p-80nt vs HO-80nt). 
3p-60nt-ssRNA and 3p-80nt-ssRNA caused cell death (Figure 1B & C), in parallel with 
their potency of IFNinduction. The cytotoxicity was not seen when the cells were 
treated with HO-80nt-ssRNA, correlating with its inability to induce IFN(Figure 13A) 
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Similar results were observed with a ssRNA of 145 nt that encodes a segment of 
luciferase (data not shown). These results are in line with the characteristics of synthetic 
ssRNA previously described by other investigators (Hornung et al., 2006; Kim et al., 
2004; Pichlmair et al., 2006). 
 
Figure 13. ssRNA induced antiviral responses in SKOV3 cells. The cells were 
transfected with a different format of ssRNA (40nM) as indicated. A, The induction of 
IFNβ mRNA were determined by RT-qPCR at 12 h post transfection. Control (Con) 
represents cells transfected with DharmaFECT without ssRNA. The results are means ± 
SD of three independent experiments. The gel inset shows the PAGE analysis of purified 
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ssRNA. B, Cell viability was determined by toluidine blue cell staining of viable cells at 
24 h post transfection. The values are means ± SD of a representative experiment 
performed in triplicates. C, Transfected cells were examined under a phase contrast 
microscope (200 x) at 48 h after toluidine blue cell staining. The images were 
photographed from a representative experiment. Arrows denote apoptotic cells. All 
representative experiments were performed at least twice with similar results. 
Short 3p-ssRNA Induced Strong Antiviral Responses in Fibroblasts but not in mESCs 
Using 3p-80nt-ssRNA characterized in SKOV3 cells, its effects on 10T1/2 cells 
were investigated, which are fibroblasts derived from early mouse embryonic tissues 
with mesenchymal stem cell properties that can differentiate into several cell lineages 
(Darland & D'Amore, 2001; Haas & Tuan, 2000). Similar to SKOV3 cells, 
3p-80nt-ssRNA induced strong IFN expression in these cells, as well as the expression 
of several other genes commonly upregulated during antiviral responses, including IL-6 
(an inflammatory cytokine), ICAM-1 (a cell adhesion molecule), and RIG-I and MDA5 
(cytosolic RNA receptors) Figure 14A, a). 3p-80nt-ssRNA also reduced cell viability in 
a dose-dependent manner Figure14A, b). The cytotoxicity caused by 3p-80nt-ssRNA 
was apparent at 12 h after transfection and significantly increased at 24 h as indicated by 
cell death and detachment Figure 14A, c).   
A time course analysis indicated that IFN induction by 3p-80nt-ssRNA was 
detectable at 7 h and dramatically increased at 14 h and 20 h post transfection Figure 
14A, d), coinciding with the onset of cytotoxicity and increased cell death. However, 
when mESCs (D3 cells) were treated with 3p-80nt-ssRNA under the same conditions, the 
induction of IFNwas negligible at 12 h treatment (Figure 14B, a) in comparison with 
10T1/2 cells and was not detected at 6 h or 24 h time points (data not shown). The 
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upregulation of IL-6 (Figure 14B, a) ICAM-1, MDA5, and RIG-I was not observed in D3 
cells (data not shown). Undifferentiated ESCs are characterized by their rapid cell 
proliferation with about 60% of cells in S phase and their growth in compact colonies. 
Transfection with 3p-80nt-ssRNA did not have detectable effects on cell viability, colony 
morphology, or cell cycle profile (Figure 14B, b, c, or d, respectively). Similar results 
were obtained when the cells were treated with 3p-80nt-ssRNA up to 100 M (data not 
shown). The different responses in 10T1/2 cells and D3 cells were not due to the 
different transfection efficiency since both cell types effectively expressed transfected 
GFP mRNA as will be discussed later.    
 
 61 
Figure 14. Comparative analysis of 3p-ssRNA induced antiviral responses in 10T1/2 
cells and D3 cells. The cells were transfected with 3p-80nt-ssRNA (40 nM). The mRNA 
levels of IFN and other gene as indicated were determined by RT-qPCR in cells 
transfected for 12 h (a). The results are means ± SD of three independent experiments. 
The cell viability was determined by toluidine blue cell staining of viable cells at 24 h 
post transfection of (b). The values are means ± SD of a representative experiment 
performed in triplicates. A time course of IFN mRNA induction in 10T1/2 cells by 
3p-80nt-ssRNA (40 nM) was determined by RT-qPCR. The values are means ± SD of a 
representative experiment performed in triplicates (A, d). The cell cycle profiles and cell 
count of D3 cells were determined with CFlow software at 24 h post transfection (Bc). 
The morphology of transfected 10T1/2 cells (Ac) and D3 cells (Bd) were examined 
under a phase contrast microscope (400 x) after TB cell staining. All representative 
experiments were repeated at least twice with similar results. 
Protein-encoding mRNA (long ssRNA) Induced Antiviral Responses in Fibroblasts and 
mESCs  
To test the effects of long ssRNA, we used the coding sequence of EGFP mRNA 
with a 3p group (3p-EGFP, 1033 nt, without cap and polyA tail). It not only strongly 
induced the expression of IFNα and IFNβ in 10T1/2 cells ~150 fold and ~5500 fold, 
respectively), but also upregulated RNA receptors (RIG-I, TLR3 and PKR) that play key 
roles in antiviral responses (Figure 15A), and caused cell death (data not shown, similar 
to the effects of 3p-80nt-ssRNA illustrated in Figure 14A, b and c). On the other hand, 
3p-EGFP mRNA only induced about 5 and 10 fold increase of IFNα and IFNβ 
respectively in D3 cells (Figure 15B), which is negligible in comparison with its effects 
on 10T1/2 cells. The 3p-EGFP mRNA did not have significant impact on cell viability or 
the morphology of D3 cells (data not shown, as illustrated in Figure14B, b and d).    
It is noted that unlike 3p-80nt-ssRNA where the removal of the 3p group 
completely abolished its immunogenicity as shown in Figure 13, the removal of the 3p 
group from EGFP mRNA significantly reduced, but did not completely abolish IFNβ 
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induction since HO-EGFP mRNA can still induce ~40 fold increase of IFNβ in 10T1/2 
cells. These observations were in line with the notion that the 3p group plays a critical role 
in type I IFN induction, but the length also contributes the immunogenicity of ssRNA 
(Hornung et al., 2006; Pichlmair et al., 2006; Schlee et al., 2009b). 
 
Figure 15. Comparative analysis of EGFP-mRNA-induced antiviral responses in 10T1/2 
cells and D3 cells. The cells were transfected with 3p-EGFP-mRNA (EGFP, 300 ng/ml). 
The mRNA levels of genes involved in antiviral response were determined by RT-qPCR. 
The results are means ± SD of three independent experiments. 
dsRNA, but not ssRNA, Activates PKR in mESCs 
dsRNA can directly activate PKR (dsRNA-activated protein kinase), which in 
turn phosphorylates eukaryotic initiation factor 2α (eIF2α) and results in a general 
inhibition of translation and cell proliferation, thereby limiting viral replication as a part 
of antiviral mechanisms (Garcia et al., 2007; Samuel, 2001). It is noted that polyIC fails 
to induce type I IFN in D3 cells, but it can activate PKR and induce a strong inhibition of 
cell proliferation (Wang et al., 2013). Since it has been reported that PKR can also be 
activated by ssRNA that have certain structural features (Nallagatla, Toroney, & 
Bevilacqua, 2011), the author analyzed the effect of 3p-EGFP mRNA on PKR activation 
in mESCs. As a positive control experiment, the transfection of D3 cells with polyIC 
significantly increased the level of phosphorylated eIF2α, indicating the activation of 
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PKR (Figure 16A, polyIC); however, transfecting the cells with 3p-EGFP mRNA did not 
show any effect as compared with the control experiment (Figure 16A, EGFP mRNA).   
It has been previously demonstrated that PKR activation by polyIC significantly 
inhibited the synthesis of cyclins, thereby inhibiting D3 cell proliferation (Wang et al., 
2013). While this effect of polyIC-induced PKR activation is reflected by the reduced 
cell number in cell proliferation analysis (Figure 16B) and by the decreased cell 
population at G2M phase in cell cycle analysis (Figure 16C), the effects of 3p-EGFP 
mRNA on these cellular processes are rather limited, if there is any.   
mESCs can Effectively Express Synthetic mRNA with Expected Biological Functions 
 
Figure 16. Effects of polyIC and 3p-EGFP-mRNA on PKR activation and cell 
proliferation. D2 cells were transfected with 300 ng/ml 3p-EGFP-mRNA (EGFP mRNA, 
coding sequence) or polyIC. A, The activation of PRK was determined by the increase of 
phosphorylated eIF2α (indicated by fluoresce intensity) with flow cytometry after 
immunostaining of the cells with antibodies against phosphorylated eIF2α Cell 
proliferation was determined by TB staining. The values are means ± SD of a 
representative experiment performed in triplicate. C, Cell cycle progression was analyzed 
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by flow cytometry. Reduction of G2/M phase cells was indicated by the arrows. All 
experiments were repeated at least twice with similar results. 
To determine if synthetic mRNA can be translated in the cells, a functional EGFP 




Figure 17. Expression of EGFP in 10T1/2 cells and D3 cells from synthetic mRNA. The 
cells were transfected with 300 ng/ml of m7GpppA-EGFP-polyA (+polyA). Control (Con) 
cells were transfected with DharmaFECT without mRNA. A, The expression of EGFP in 
D3 cells was examined with a fluorescence microscope at 18 h and 48 h after one time 
transfection. B, The expression of EGFP in D3 cells from m7GpppA-EGFP-polyA 
(+polyA) or m7GpppA-EGFP (-polyA) was quantified with a fluorescence plate reader 
within a time course from 18-48 h. C, D3 cells were transfected with 
m7GpppA-EGFP-polyA once or twice (1x & 2x, respectively). The expression of EGFP 
was examined with a fluorescence microscope at 24 h of each transfection. The cells 
after second transfection were split into new culture dishes, where they received third (3x) 
and fourth transfection (4x) following the same protocol used for the first two rounds of 
transfections. The cells were examined for EGFP expression with a fluorescence 
microscope (middle panels) and for cell morphology with a phase contrast microscope 
(bottom panels). D, The number of viable cells (determined by OD630 nm) was 
determined by TB staining at 24 h after third (3x) and fourth (4x) transfection. E, 10T1/2 
cells were transfected m7GpppA-EGFP-polyA under the same conditions as described for 
D3 cells and examined for EGFP expression and for cell morphology. F, The relative 
number of viable cells was determined by TB staining at the end of the experiment (40 h 
for 10T1/2 cells and 48 h for D3 cells for comparison). The values are means ± SD of a 
representative experiment performed in triplicates. All experiments were repeated at least 
twice with similar results. 
After transfection, EGFP expression was detected in D3 cells as early as 12 h, and 
the fluorescence intensity progressively increased in a time course from 18 h to 48 h as 
determined by fluorescence microscopy and by spectrometric analysis (Figure 17A& B), 
whereas very limited EGFP expression was detected with an EGFP mRNA without a poly 
A tail (m7GpppA-EGFP) (Figure 17B, -polyA). In a separate experiment, D3 cells grown 
at low density were transfected with m7GpppA-EGFP-polyA, and were then transfected a 
second time after 24 h. The expression of EGFP was analyzed under a fluorescence 
microscope at 24 h after each transfection. EGFP was effectively expressed after each 
transfection with a significant increase of EGFP florescence intensity after the second 
transfection (Figure 17C, 1x vs 2x). After second transfection, the cells quickly reached 
confluence. Therefore, they were split into new culture dishes where they received third 
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and fourth transfection. Similar to the first two rounds of transfection, EGFP was 
effectively expressed under both low (Figure 17C, 3x) and high density (Figure 17C, 4x) 
growth conditions. The transfection of ESCs grown in low density slightly decreased the 
cell number, but such effect was not obvious in cells at a high density (Figure 17D, 3x 
and 4x, respectively). These results demonstrated that ESCs can tolerate repeated mRNA 
transfection and effectively translate the synthetic mRNA without losing cell viability.  
When 10T1/2 cells were transfected with m7GpppA-EGFP-polyA, EGFP was 
detected at 18 h, similar to its expression in D3 cells. However, the cells began to lose 
viability around 30 h after transfection, concurrent with a decrease in fluorescence signal. 
EGFP expression was significantly diminished with only about 60% of cells remaining 
viable as compared with the control cells at 40 h (Figure 17E, F). Therefore, even after 
being capped and polyadenylated, the functionalized mRNA can still cause a strong 
toxicity in 10T1/2 cells, although the synthetic mRNA can be translated at an early stage 
of transfection before the cells mount strong antiviral responses.  
To further determine the functionality and compatibility of synthetic mRNA with 
mESCs, D3 cells were transfected with the Etv2 mRNA (m7GpppA-Etv2-polyA), a 
member of the ETS transcription factor family that directly transactivates several genes 
required for vascular development (De Val & Black, 2009; Ginsberg et al., 2012). As 
shown in Figure 18, several genes essential for endothelial cell specification (known 
target genes of Etv2) were upregulated to different degrees in D3 cells transfected with 
Etv2 mRNA (Figure 18A), demonstrating the expected transcription activity of Etv2. 
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However, the three genes most upregulated in D3 cells, Flk1, Fli1, and 
VE-cadherin (VE-Cad), were not significantly affected in 10T1/2 cells (Figure 18B). 
Similar to EGFP mRNA, Etv2 mRNA transfection did not affect the viability of D3 cells, 
but caused significant cytotoxicity in 10T1/2 cells (Figure 18C & D). 
 
Figure 18. Expression of Etv2 from its synthetic mRNA in 10T1/2 cells and D3 cells. The 
cells were transfected with m7GpppA-Etv2-polyA (300 ng/ml) for 48 h. A, B, The effects 
on the expression of Etv2 regulated genes were determined by RT-qPCR analysis. The 
results are means ± SD of three independent experiments. C, The morphology of 
transfected cells were examined under a phase contrast microscope (400x) after TB cell 
staining. D, The relative number of viable cells was determined by TB staining at the end 
of the experiment. The values are means ± SD of a representative experiment performed 
in triplicates that was repeated at least twice with similar results.   
These results correlated with the strong induction of IFNα/β by Etv2 mRNA in 
10T1/2 cells, but not in D3 cells (Figure 18E). Therefore, the failure of Flk1, Fli1, and 
VE-cadherin expression in 10T1/2 cells can be logically explained by the fact the 
antiviral responses, especially PKR activation and cytotoxicity, are known factors to 
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strongly inhibit protein synthesis in the host cells (Garcia et al., 2007; Samuel, 2001). It is 
conceivable that the antiviral responses induced by Etv2 mRNA in 10T1/2 cells will 
inhibit its own translation, resulting in no transcription activation required for the target 
genes (Flk1, Fli1 and VE-cadherin).  
Chemical Modifications Reduce, but not Eliminate the Immunogenicity of Synthetic 
mRNA 
The 3p group is an intrinsic part of RNA synthesized by in vitro transcription 
(Huang, He, Zhang, & Guo, 2008). When the mRNA is capped and polyadenylated, the 
functionalized synthetic mRNA still can induce strong antiviral responses as shown in 
10T1/2 cells, and other investigators have reported in other types of fibroblasts (Angel & 
Yanik, 2010). Base modifications of the mRNA during in vitro transcription have been 
used to reduce the immunogenicity. However, cell reprogramming requires repeated 
transfection. Therefore, the modified mRNA must be used in combination with either 
siRNA knocking down the RNA receptors in the host cells or inhibitors of IFN signaling 
pathway (Warren et al., 2010). To test how mESCs respond to mRNA modifications, a 
fully functional GFP mRNA with base modifications (purchased from Stemgent) was 
used. It also contains a nuclear localization signal sequence that directs the translated GFP 
to the nucleus (designated as nGFP-mRNA). The nGFP mRNA was effectively translated 
in both 10T1/2 cells and D3 cells and detected in the nucleus as expected after 
transfection for 24 h (Figure 19A, 1x). The cells did not display detectable cytotoxicity 
within 48 h of transfection. However, subsequent transfection for the second time resulted 
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in a dramatically increased cytotoxicity in 10T1/2 cells (30-50% loss of viable cells) and 
significantly diminished GFP expression. 
 
Figure 19. Base-substitution of synthetic nGFP mRNA reduces but not eliminates its 
immunogenicity. The cells were transfected with a synthetic nGFP-mRNA (nGFP, 300 
ng/ml) that has been modified by base modifications. A, The transfection was performed 
twice (1x & 2x) with a 48 h interval. The expression of GFP was exampled with a LSM 
confocal florescence microscope at 24 h after each transfection. The boxed area 
(10T1/2:nGFP 1x) shows enlarged cells to illustrate the nuclear location of GFP. The 
morphology of transfected cells was examined under a phase contrast microscope after 
TB staining (400x). B, The mRNA levels of IFNβ, RIG-I, PKR and TLR3 were 
determined by RT-qPCR in the cells that were transfected second transfection for 12 h. 
The results are means ± SD of three independent experiments.  
On the contrary, the second transfection substantially increased GFP expression in 
D3 cells without causing cell death (Figure 19A, 2x), similar to the results obtained from 
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EGFP mRNA synthesized in our laboratory without base modifications (Figure 19). It is 
noted that the first transfection with nGFP-mRNA did not induce IFNβ expression in 
10T1/2 cells or in D3 cells (data not shown), but the second transfection induced the 
expression of IFNβ and RNA receptors in 10T1/2 cells (10-20 fold) while the effects in 
D3 cells were negligible (Figure 19B). The results from 10T1/2 cells suggested that base 
modifications of synthetic mRNA can reduce, but cannot eliminate the immunogenicity. 
Discussion 
      After confirming the deficiency of mESCs in expressing type I IFN when 
exposed to viral infection and dsRNA viral analogs, it is interesting to investigate their 
responses to different formats of synthetic ssRNA as viral ssRNA mimics. Short ssRNA 
induced antiviral responses in highly differentiated epithelial cells (SKOV3 cells) in a 
manner that depends on the length and the presence of 5'-3p group. Even less 
differentiated fibroblasts with mesenchymal stem cell properties (10T1/2 cells) displayed 
strong antiviral responses to 3p-ssRNA and mRNA. These results are consistent with 
features of ssRNA characterized in other types of somatic cells (Hornung et al., 2006). 
None of the cellular effects associated with antiviral responses were observed in mESCs. 
Together with the results previously obtained from viral infection and dsRNA (Wang et 
al., 2013), the current study provided additional evidence to a general conclusion that 
mESCs have underdeveloped antiviral mechanisms.    
RNA-induced type I IFN expression is mediated by toll-like receptors 3 and 7 
localized on the cell surface or on the endosomal membrane and by RIG-I and MDA5 
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localized in the cytosol (Kawai & Akira, 2011; Stetson & Medzhitov, 2006). Apparently, 
none of these receptors are functional in mESCs with respect to IFN induction based on 
this study’s results with live viral infection, dsRNA (Wang et al., 2013) and ssRNA (this 
chapter). Although the detailed molecular mechanisms remain to be elucidated, the low 
level expression of RNA receptors and their signaling components in ESCs could be at 
least partly responsible for the deficient antiviral responses (Chen et al., 2010; Wang et 
al., 2013). RIG-I is the major receptor that mediates the effects of viral ssRNA and 
synthetic ssRNA, especially those with a 3p-group (Hornung et al., 2006; Kim et al., 
2004; Pichlmair et al., 2006; Schlee et al., 2009b). In addition to its well-defined function 
in inducing type I IFN, a recent study showed that RIG-I activation leads to apoptosis by a 
mechanism that is independent of IFN expression in SKOV3 cells (Besch et al., 2009). 
Therefore, the RIG-I pathway may play a major role in mediating the IFNβ expression 
and cytotoxicity induced by ssRNA, as demonstrated in 10T1/2 cells where 
3p-80nt-ssRNA induced IFNβ expression and cell death within a similar time course. 
Apparently, the antiviral responses elicited by ssRNA through the RIG-I pathway 
typically seen in differentiated cells are not induced in ESCs. The only pathway that is 
functional in mESCs seems to be the PKR pathway, which is activated by polyIC and 
responsible for polyIC-induced inhibition of translation and cell proliferation as the 
author previously reported (Wang et al., 2013). Although best characterized as 
dsRNA-activated kinase, recent studies have indicated PKR can be also activated by 
ssRNA depending on certain structural features of ssRNA and that there is a synergistic 
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involvement of RIG-I and IFN (Nallagatla et al., 2011; Nallagatla et al., 2007). The 
failure of ssRNA to activate PKR in mESCs can be explained by the inactive status of the 
RIG-I pathway and defected IFN expression mechanism in these cells. 
The expression of type I IFN in response to viral infection is the central part of the 
innate immunity developed in most types of somatic cells. The lack of this mechanism to 
viral infection and the lack of inflammatory responses to bacterial challenge in ESCs 
indicated that “innate immunity” is, in fact, not developed in ESCs and has to be acquired 
during or after their differentiation to other cell types (Yu, Rossi, Hale, Goulding, & 
Dougan, 2009). While these findings opened up an important area in ESC research for 
understanding the development of innate immunity during embryogenesis, it is 
particularly exciting that the underdeveloped antiviral responses in ESCs may provide a 
“natural solution” to resolve the most challenging issue in application of 
mRNA-mediated gene expression. As discussed earlier, the problems associated with 
antiviral responses induced by synthetic mRNA are not insurmountable, but the need of 
complex modifications is obviously a major barrier for their application. These data 
demonstrated that 5’ capping and 3’ polyadenylation of mRNA is not sufficient to repress 
the immunogenicity of long ssRNA since a single transfection of 10T1/2 cells with 
m7GpppA-EGFP-polyA (without base modifications) caused significant cell death. Base 
modification of mRNA reduces the immunogenicity since transfection of 10T1/2 cells 
with nGFP-mRNA (with base modifications) resulted in GFP expression without causing 
serious cytotoxicity. Therefore, the difference in immunogenicity between the two 
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GFP-mRNAs is likely due to base modifications. However, it is interesting to note that 
the effect of base modifications can reduce, but not eliminate the immunogenicity of the 
mRNA since the effect is limited to a single transfection and the subsequent transfection 
resulted in apparent antiviral responses in 10T1/2 cells. These findings can be explained 
by a well-documented phenomenon in antiviral responses; through a positive feedback 
loop, an initial weak stimulus (the first mRNA transfection in our case) can upregulate 
the antiviral signaling pathways, thereby “priming” the cells to mount stronger antiviral 
responses to the subsequent stimulus (second mRNA transfection) (Huang et al., 2006; 
Matsumoto & Seya, 2008; Pan et al., 2011).  
Therefore, immunogenicity intrinsically associated with mRNA (long ssRNA, 
sequence independent) can sensitize the host cells that have active antiviral mechanisms 
to repeated mRNA transfection. Without other interventions, such as the knockdown of 
RNA receptors in the host cells or using inhibitors of IFN signaling pathway, base 
modification of mRNA alone is not sufficient for successful cell reprogramming that 
needs multiple mRNA transfections (Angel & Yanik, 2010; Warren et al., 2010). On the 
other hand, mESCs can be repeatedly transfected even with unmodified 3p-mRNA 
(ssRNA with the most potent immunogenicity) and can effectively translate functional 
proteins from the synthetic mRNA either with or without nucleotide modifications.   
The ultimate goal of ESC research is to generate clinically usable ESC-derived 
cells for regenerative medicine. It is increasingly clear that obtaining ESC-derived cells 
with clinical quality by existing methods is a difficult task. Based on the same principle 
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and methodology for iPSC reprogramming, a recent study demonstrated that the forced 
expression of three transfection factors (Etv2, Fli1 and Erg1) that control vascular 
differentiation effectively converted hESCs to endothelial cells with significantly 
increased yield and maturity (De Val & Black, 2009; Ginsberg et al., 2012). This study 
demonstrates that intervention at the transcriptional level can provide a strong internal 
driving force for cell specific differentiation. However, the expression of the 
aforementioned transcription factors in that study is also mediated by viral vectors 
(Ginsberg et al., 2012). Using synthetic mRNA as an alternative gene expression 
approach may avoid the safety concerns associated with viral vectors. It should be 
pointed out that mRNA-mediated gene expression described in this study was carried out 
in undifferentiated mouse ESCs. Generating specific cell types from ESCs must be 
performed under differentiation conditions and other specific requirements. For example, 
generating mature and functional endothelial cells from ESCs requires a complex 
protocol that needs simultaneous expression of Etv2, Fli1, and Erg1 and in combination 
with repression of TGFβ signaling (Ginsberg et al., 2012). The effort toward that goal is 
underway in our laboratories. 
In conclusion this and the previous chapters demonstrate that mESCs have 
underdeveloped antiviral mechanisms. This finding represents a unique and previously 
uncharacterized property of mESCs that is not only important for understanding innate 
immunity development, but can also be exploited for developing mRNA-based gene 
expression methods that may transform the existing differentiation paradigms. 
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CHAPTER V 
ANTIVIRAL RESPONSES IN MOUSE EMBRYONIC STEM CELLS: 
DIFFERENTIAL DEVELOPMENT OF CELLULAR MECHANISMS IN TYPE I 
INTERFERON PRODUCTION AND RESPONSE 
Introduction 
      Type I IFNs, including IFNα, IFNβ, IFNε, and IFNω, are synthesized and 
secreted by most virally infected somatic cells, while type II IFNs are mainly produced 
by certain immune cells (Samuel, 2001). After being secreted, type I IFN family 
members bind the same cell surface receptor complexes and transduce signaling through 
the same signaling pathway. 
Type I IFN signaling pathway 
IFNα/β receptors transduce signals though receptor-associated Janus family of 
tyrosine kinases (JAK) (Figure 20). Jak1 (conjugated with IFNAR2) and Tyk2 
(associated with IFNAR1) are activated by the binding of type I IFNs to receptors 
(Mogensen, Lewerenz, Reboul, Lutfalla, & Uze, 1999). Then activation of Jak1 and Tyk2 
leads to phosphorylation of the signal transducer and activator of transcription (STAT) 
family proteins Stat1 and Stat2. Phosphorylated Stat1 and Stat2 form heterodimers and 
associate with another protein belonging to the IFN regulatory factor family IRF9 (p48), 
resulting in the formation of the interferon stimulated gene factor 3 (ISGF-3), which then 
translocates into the nucleus to trigger downstream gene expression through binding to 
the interferon stimulated response elements (ISREs) (Darnell, 1997; Stark, Kerr, Williams, 
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Silverman, & Schereiber, 1998). ISREs are cis-acting DNA elements responsible for the 
type I IFN-induced gene expression with the consensus sequence AGTTTCNNTTTCNPy, 
which is the binding site for ISGF-3 and some IRFs (Darnell, 1997; Leonard & O'Shea, 
1998).  
 
Figure 20. Type I IFN downstream signaling. JAK family kinases conjugated with 
IFNAR are activated through type I IFN binding to receptors and promote 
phosphorylation of STAT1 and STAT2, which form a complex with IRF-9 to induce 
expression of ISG. (Masumi, 2013) 
The cell surface receptor of type I IFN consists of 2 subunits: IFNAR1 and 
IFNAR2. Upon binding type I IFN, 2 subunits form a heterodimer (Samuel, 2001). 
IFNα/β receptors play essential roles in anti-viral immunity as evidenced by the failure of 
IFNα/β null mice to establish an anti-viral state.  
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 Several negative regulators exist in cells to control the amplitude and duration of 
type I IFN signaling. Proteins in the family of the suppressor of cytokine signaling 
(SOCS) cast negative regulation on the JAK-STAT pathway (Naka, Fujimoto, & 
Kishimoto, 1999; Starr et al., 1997). They all have two characteristic conserved domains, 
a central SH2 domain and a SOCS box at the C-end (Naka et al., 1999; Starr et al., 1997). 
SOCS proteins which are expressed at low basal levels can be induced by IFN signaling 
and form a negative feedback loop, inhibiting IFN signaling by suppressing JAK kinase 
activation (Endo et al., 1997). SOCS1 is an important regulator of innate immunity that 
efficiently inhibits STAT1 phosphorylation (Alexander et al., 1999; Brysha et al., 2001). 
In addition to SOCS family members, protein inhibitor of activated stat-1 (PIAS-1) can 
also suppress IFN signaling by directly binding to Stat1, blocking its DNA-binding 
activity (Liao, Fu, & Shuai, 2000; Liu et al., 2004). Another way to counteract IFN 
signaling is to dephosphorylate target molecules. SH-2 containing phosphatase-1 (SHP-1) 
directly interacts with and dephosphorylates JAKs to suppress various cytokine signaling 
(David, Chen, Goelz, Larner, & Neel, 1995).  
IFN-induced effectors 
  Type I IFNs can suppress a wide range of viral replication in vitro and in vivo. 
Their effects are mediated by more than 200 downstream genes induced by IFN signaling, 
including double-stranded RNA dependent protein kinase (PKR), 2’,5’-oligoadenylate 
synthetase (OAS), the RNA-specific adenosine deaminase (ADAR), and the Mx protein 
GTPase (Samuel, 2001).  
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PKR  
PKR is an IFN-induced, RNA-dependent protein kinase with multiple substrates 
(Clemens, 1997). While PKR is mainly found in the cytoplasm and associated with 
ribosomes, some amounts of PKR localize to the nucleus after IFN treatment 
(Jimenez-Garcia, Green, Mathews, & Spector, 1993; Samuel, 1993; Thomis, Doohan, & 
Samuel, 1992). After being induced and activated, PKR phosphorylates various substrates 
to mediate different biological consequences. 
 
Figure 21. Functions of some IFN-induced proteins. PKR inhibits translation of viral and 
cellular RNA by phosphorylating eIF-2α; 2’,5’-oligoadenylic acid, which is synthesized 
through OAS catalysis, activates RNase L to degrade viral and cellular RNA; ADAR1 
converts adenosine in the cellular and viral RNA to inosine to affect their function and 
stability; Mx family GTPases interfere with the viral replication directly through 
targeting viral nucleocapsids and RNA synthesis. (Samuel, 2001) 
Translation control and eIF2α: In mammals, eIF2 (consisting of α, β and γ) 
subunits binds Met-tRNA in a GTP-dependent manner to promote its delivery to the 40S 
ribosome subunit (Hershey, 1991; Majumdar & Maitra, 2005). Once Met-tRNA is 
 79 
delivered, eIF2 dissociates from the 48S initiation complex via eIF5-dependent GTP 
hydrolysis (Hershey, 1991; Majumdar & Maitra, 2005). Active eIF2-GTP complexes are 
continuously regenerated by GDP-GTP exchange catalyzed by eIF2B. After 
phosphorylation on Ser51 of eIF2α, affinity of eIF2 to eIF2B increases for 100-fold, 
leading to the inhibition of eIF2B and translation initiation (Sudhakar et al., 2000). Given 
that the concentration of eIF2B is low compared with eIF2, a small increase in eIF2α 
phosphorylation will cause an exacerbated effect on protein synthesis (Hershey, 1991).  
 Phosphorylation of eIF2α serves not only as a control on protein synthesis but 
also as response to stress conditions. Four kinases (PKR, GCN2, PERK, and HRI) that 
can exert this modification sense stress signals and regulate cell responses (Dever, 2002).  
 Although translation of most mRNAs is inhibited by eIF2α phosphorylation, few 
mRNAs involved in stress response get enhanced translation. These genes include yeast 
GCN4 and mammalian activating transcription factor 4 (ATF-4), ATF-3, and CAT-1 
mRNAs (Dever et al., 1992; Guerra, Lopez-Fernandez, Garcia, Zaballos, & Esteban, 
2006; Lu, Harding, & Ron, 2004; Yaman et al., 2003). Translation of these mRNAs is 
inhibited by the upstream short open reading frame (ORF) for short peptides in normal 
condition, while a reduced number of active initiation complex promotes re-initiation at 
bona fide GCN4 and ATF-4 ORFs to give functional proteins under stress conditions 
because eIF2α phosphorylation limits the number of active 43S complexes (Dever, 2002). 
Moreover, some viral mRNAs can make use of a stable stem-loop structure downstream 
of the AUG codon that stalls the ribosomes on the correct site for translation initiation, 
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while others can use eIF2A instead of eIF2 to deliver the Met-tRNAi and initiate 
translation under high level of eIF2α phosphorylation (Ventoso et al., 2006; Wilson, 
Pestova, Hellen, & Sarnow, 2000).  
 PKR was first related with its effects on protein synthesis and its substrate eIF2α. 
PKR is one of 4 kinases that phosphorylate eIF2α (Barber, 2001; Dever, 2002; Harding et 
al., 2000; Williams, 1999, p. 6112). Phosphorylation on serine51 of eIF2α prevents the 
recycling of this factor required for ongoing translation, causing general translational 
inhibition (Garcia et al., 2006). So accumulated dsRNAs activate PKR, triggering 
phosphorylation of eIF2α and inhibiting translation of viral mRNA (Balachandran et al., 
2000; Lee, Bablanian, & Esteban, 1996; Lee et al., 1993; Stojdl et al., 2000). It has been 
shown that phosphorylation on Thr446 is essential for substrate recognition and 
modification (Su et al., 2006). Furthermore, as a translation regulator, PKR was found to 
associate with ribosomes, mainly 40S subunits (Kumar, Srivastava, & Kaufman, 1999; 
Zhu, Romano, & Wek, 1997). The PKR localization in ribosomes explains the local 
activation pattern of PKR in response to limited stimuli (Balachandran et al., 2000; 
Ben-Asouli et al., 2002; Kaufman, Davies, Pathak, & Hershey, 1989; Zhu et al., 1997). 
This localization and activation pattern may guarantee specificity and efficiency of PKR.  
IRF-1: PKR was reported to mediate the growth inhibitory activity of IRF-1 
(Kirchhoff et al., 1995). On the other hand, IRF-1 may mediate PKR-triggered apoptosis 
(Der, Yang, Weissmann, & Williams, 1997). Supporting this view, the activation of IRF-1 
in response to IFNγ and polyIC is defective in PKR null mice (Kumar et al., 1997).  
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      STAT: PKR associates with STAT1 in a kinase-independent manner and may 
inhibit the DNA binding activity of STAT1 (Wong et al., 1997). PKR can also regulate 
phosphorylation of STAT1 indirectly through the ERK-MAPK pathway (Ramana et al., 
2000). As mentioned above, PKR is required for full activation of STAT3 and 
downstream gene induction in response to PDGF (Deb, Zamanian-Daryoush, Xu, 
Kadereit, & Williams, 2001b). 
 
Figure 22. Substrates and biological effects of PKR. PKR, which can be activated by 
double-stranded RNA and cell stresses, phosphorylates a broad range of substrates 
including eIF2α, NF-κB, JNK, and p38, leading to diverse biological consequences. 
(Kirkegaard, Taylor, & Jackson, 2004) 
 Studies have shown that cells or mice deficient in PKR exhibit impaired responses 
to different TLR ligands, implying the involvement of PKR in TLR signaling (Goh, 
deVeer, & Williams, 2000). Supporting this view, PKR has been shown to interact with 
TIRAP and is phosphorylated in LPS-stimulated macrophages (Horng et al., 2001). PKR 
is also activated in TLR9 signal transduction in response to CpG (Horng et al., 2001). 
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Moreover, PKR is also engaged in dsRNA-activated TLR3 signaling via recruitment to 
TAK1-containing complex (Jiang et al., 2003).  
 PKR is phosphorylated and activates expression of immediate early gene c-fos in 
response to platelet-derived growth factor (Deb et al., 2001b; Mundschau & Faller, 1995). 
After being activated by PDGF, PKR plays important roles in phosphorylating STAT3 on 
Serine727 (Deb et al., 2001b). Also, PKR null MEF shows deficient p38 activation in 
response to IL-1 (Goh et al., 2000). 
 PKR serves as an activator of signaling in stress activated protein kinases and 
mediates activation of JNK and p38MAPK (Chu et al., 1999; Goh et al., 2000). PKR is 
required for the full activation of JNK and p38 in response to LPS and cytokines (Goh et 
al., 2000). Using PKR knockout MEF, PKR has been shown to be required for p38 
MAPK activation in response to dsRNA, LPS, and proinflammatory cytokines but not in 
response to other forms of stress (Goh et al., 2000).  
 Biological consequences of PKR activation are diverse, affecting cell proliferation, 
cell death, and differentiation. Most effects of PKR activation can be explained by the 
signaling pathways in which it is involved. For example, apoptotic induction can be 
related with phosphorylation of eIF2α, NF-κB, p53, and ATF-3 (Garcia et al., 2006).  
 PKR has been implicated in cycle regulation. However, its effects seem to be 
complex and context-dependent because PKR activity is widely related with various 
signaling pathways. Aside from possible involvement of p53 or NF-κB, phosphorylation 
of eIF2α has been shown to cause delayed G1-S transition. PKR and PERK induce 
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proteasome-dependent degradation of cyclin D1 through eIF2α phosphorylation, leading 
to G1 arrest (Raven et al., 2008). Also, these two kinases promote degradation of p53 via 
GSK3 activation (Baltzis et al., 2007). On the other hand, GCN2, an eIF2α kinase, 
inhibits loading of components of pre-replication complex (pre-RC) to induce a novel G1 
checkpoint under UV irradiation in yeast (Tvegard et al., 2007).  
OAS and RnaseL 
IFN signaling promotes the degradation of viral and cellular RNA and involves 
two enzymes: 2’,5’-oligoadenylate synthetase (OAS) and Rnase L. In the first step, OAS 
catalyzes the synthesis of oligoadenylates through using ATP in a 2’-specific nucleotidyl 
transfer reaction (Kerr & Brown, 1978). Then, in the second step, a latent 
endoribonuclease, Rnase L, is activated through binding to newly synthesized 2-5 A 
oligonucleotides.  
Three forms of OAS (OAS1, OAS2, and OAS3) have been identified in human 
cells (Reubinoff et al., 2000). Oligomerization of OAS1 and OAS2, which form tetramers 
and dimers, respectively, is necessary for their activation (Ghosh, Sarkar, Guo, 
Bandyopadhyay, & Sen, 1997; Sarkar, Ghosh, Wang, Sung, & Sen, 1999). Like PKR, 
OAS is activated by dsRNA and possesses separate subdomains responsible for 
RNA-binding activity and enzymatic activity (Reubinoff et al., 2000; Sarkar & Sen, 
1998). However, there is no obvious homology in the dsRNA-binding regions of OAS 
proteins and PKR (Ghosh et al., 1991). OAS enzymes are activated during viral infection, 
although in most conditions the exact RNA activators have not been well-defined 
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(Reubinoff et al., 2000). The induction of OAS by IFN varies in different cell types and 
growth state. For example, 10-fold increase was found in Hela cells with a high basal 
enzyme level while OAS can be induced by 10,000 fold in chicken embryonic cells 
which have a low basal level (Baglioni, Maroney, & West, 1979; Ball, 1979). All three 
forms of OAS can be induced by IFNα, IFNβ, and IFNγ (Chebath, Benech, Hovanessian, 
Galabru, & Revel, 1987). 
Rnase L, normally residing in the cells as latent and inactive monomers, requires 
the presence of functional 2-5A oligomers to form stable homodimers and acquire 
endoribonuclease activity (Dong & Silverman, 1995; Dong et al., 1994; Hassel, Zhou, 
Sotomayor, Maran, & Silverman, 1993). The ability of 2-5A to mediate dimer formation 
of Rnase L correlates with its ability of activation (Dong & Silverman, 1995). After being 
activated, Rnase L promotes the degradation of both viral and cellular RNAs, including 
rRNA, through cleaving the the UpXp sequences on the 3’ side (Floyd-Smith, Slattery, & 
Lengyel, 1981; Wreschner, McCauley, Skehel, & Kerr, 1981). Rnase L is constitutively 
expressed and present in cells, although Northern blot showed that type I IFN increases 
the steady-state amount of Rnase L mRNA by three folds in mouse cells (Floyd-Smith & 
Denton, 1988; Zhou, Hassel, & Silverman, 1993). Knocking out Rnase L genes 
effectively produces a phenotype of 2-5A knockout model, since the only function of 
2-5A is to activate latent Rnase L (Samuel, 2001). Rnase L knockout mice die more 
rapidly than the wild type control under the infection with EMC viruses (Zhou et al., 
1997; Zhou, Paranjape, Der, Williams, & Silverman, 1999). Also, deficiency in apoptosis 
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has been reported in Rnase L knockout MEF (Zhou et al., 1997). IFN-induced transcripts 
may be further elevated in cells without functional Rnase L. The 2-5A system may 
function to attenuate and limit IFN response by destabilizing IFN-induced mRNAs, a 
hypothesis supported by kinetic analysis of Rnase L knockout and wildtype MEF (Li et 
al., 2000). 
Other IFN regulated genes  
Gene expression and function can be regulated and altered at the 
post-transcriptional level by RNA modification. For example, the deamination of 
adenosine to yield inosine provides an efficient way to control or alter functions of viral 
and cellular RNA (Bass, 1997; Cattaneo, 1994). Double-stranded RNA-specific 
adenosine deaminase (adenosine deaminase acting on RNA, ADAR1), one important 
RNA editing enzyme, is a downstream target of IFN (George & Samuel, 1999; Patterson, 
Thomis, Hans, & Samuel, 1995; Patterson & Samuel, 1995). A-to-I transitions catalyzed 
by ADAR destabilize the dsRNA helix to the favor single stranded character because the 
newly generated IU pair is unstable compared with the original AU base pairs (Bass & 
Weintraub, 1988). Moreover, the translation of modified RNA can be affected since 
hypoxanthine, which is the base of inosine, is typically recognized as guanine by 
translational machinery (Alberts et al., 1994).  
Protein MxA (human) and Mx1 (mouse) of the MX family proteins have been 
well-characterized in IFN-induced anti-viral activity, evidenced by the finding that Mx 
alone is enough to block replication of virus in the absence of any other type I IFN 
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downstream genes (Arnheiter, Frese, Kambadur, Meier, & Haller, 1996; Haller, Frese, & 
Kochs, 1998). The anti-viral activity depends on their intrinsic GTPase activity (Pitossi et 
al., 1993). Mx proteins are induced only by type I IFN but not IFNγ or other cytokines 
(Arnheiter et al., 1996; Simon, Fäh, Haller, & Staeheli, 1991). The mechanisms and 
spectrum of antiviral activity of Mx proteins depend on their subcellular localization and 
the type of infection. 
Correlating with their subcellular localization, Mx1 blocks the multiplication of 
influenza virus mainly at the step of transcription catalyzed by the virion-associated 
polymerase, while the human MxA interacts with the viral nucleocapsid by binding to the 
NP nucleoprotein component (Kochs & Haller, 1999; Krug, Shaw, Broni, Shapiro, & 
Haller, 1985; Pavlovic, Haller, & Staeheli, 1992).  
Interferon stimulated gene 15 (ISG15) is a ubiquitin-like protein induced by IFNs 
(Morales & Lenschow, 2013). ISG15 forms conjugates with a large population of target 
proteins through the process called LSGylation which involves E1 activating enzymes, 
E2 conjugating enzymes and E3 ligases. Many important ISGs have been identified as 
ISG15 targets. ISGylation of IRF3 stabilizes activated IRF3, thus helping to maintain 
type I IFN signaling (Lu et al., 2006; Shi et al., 2010). RIG-I was also found to be 
ISGylated and thus down-regulated in protein levels, dampening the IFN responses (Kim, 
Hwang, Imaizumi, & Yoo, 2008). PKR was found to be activated in the absence of RNA 
in a ISG15-dependent manner as supported by the fact that such RNA-independent 
activation cannot be induced in a non-ISGylatable PKR (Okumura et al., 2013). Other 
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than host proteins, viral proteins like NS1 protein of influenza A virus and capsid protein 
of HPV were shown to be ISGylated, leading to reduced replication or infectivity (Durfee, 
Lyon, Seo, & Huibregtse, 2010; Tang et al., 2010; Zhao, Hsiang, Kuo, & Krug, 2010). 
Moreover, unconjugated ISG15 secreted to extracellular space protected mice from 
CHIKV induced lethality through regulating production of cytokines and chemokines 
(Werneke et al., 2011).  
The above-mentioned genes are the most well-established IFN-induced anti-viral 
effectors in a single cell model. Some other proteins like major histocompatibility 
complex proteins are involved in multiple-cell interactions (Samuel, 2001). More than 
100 out of 6800 human genes were identified to be differentially regulated by IFN 
treatment of human fibrosarcoma cell line (Der, Zhou, Williams, & Silverman, 1998). A 
IFN response is a broad-reaching reaction with a genomic change of gene expression. 
Methods 
Cell culture  
D3 and DBA252 mESCs were maintained in the standard mESC medium as 
previously described (Wang et al., 2013). C3H10T1/2 (10T1/2, a line of mouse 
embryonic fibroblasts, ATCC) were cultured in DMEM that contains 10% fetal calf 
serum and 100 units/ml penicillin and 100 g/ml streptomycin. All cells were maintained 
at 37 °C in a humidified incubator with 5% CO2. Most experiments were performed with 
D3 cells, and key results were confirmed with DBA252 cells. 
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Preparation of virus stocks and titer determination   
La Crosse virus (LACV, SM6 v3), West Nile virus (WNV, strain CT 2741) and 
Chikungunya virus (CHIKV, LR 2006 OPY 1 strain) were propagated in Vero cells 
(African green monkey kidney cell line, ATCC). Titers of virus stocks were determined 
by plaque assay as previously described (Bai et al., 2005).  
Cell treatment  
mESCs and 10T1/2 cells were plated at ~40% and ~70% confluence, respectively 
and cultured for ~24 h before experiments. The conditions for cell infection with 
different viruses were specified in individual experiments. The cellular responses to type-I 
IFNs were determined with mouse recombinant IFN(IFN2, 1x108 U/mg, eBioscience) 
and human recombinant IFN or IFN (5x108 U/mg, 1x108 U/mg, respectively, 
Peprotech) that are active on mouse cells. The effects of IFNs on viral replication were 
determined by viral titers in the media of infected cells. For polyIC 
(polyinosinic:polycytidylic acid, a synthetic dsRNA) treatment, the cells were transfected 
with polyIC using a DharmaFECT reagent (Thermo Scientific). The control cells were 
transfected with the DharmaFECT reagent alone.  
Immunodetection of STAT1 nuclear translocation  
Immunostaining was performed according to our published method (Wang & Guo, 
2012). Briefly, treated cells were fixed with 4% paraformaldehyde. They were then 
incubated with antibodies that recognize phosphorylated STAT1 (pSTAT1, Cell Signaling 
Technology) followed by an incubation with rhodamine-conjugated secondary antibodies. 
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The cells were then analyzed under a LSM 510 laser-scanning confocal microscope 
(Zeiss).  
siRNA transfection   
siRNA targeting SOCS1 (Santa Cruz Biotechnology) were transfected to the cells 
with the DharmaFECT reagent as previously described (Wang et al., 2013). The cells 
were then analyzed for knockdown efficiency and for mRNA levels of SOCS1.  
 Reverse transcription Real-time quantitative polymerase chain reaction 
(RT-qPCR), cell proliferation, viability, and cell cycle analysis, protein analysis by flow 
cytometry, and Western blot, and statistical analysis were described in the Method part of 
Chapter III. 
Results 
IFNβ and IFNω Protect mESCs from LACV Induced Cell Death  
Antiviral activity is considered the most important physiological function of type 
I IFNs. Previous data have shown that mESCs and 10T1/2 cells (a mouse embryonic 
fibroblast cell line) are susceptible to LACV-induced lytic cell death (Wang et al., 2013). 
Therefore, these cells were used to analyze the antiviral effects of IFNβ and IFNω, a best 
studied and a less characterized type I IFNs, respectively.  
As shown in Figure 23A, LACV infection caused about 50% cell death in 10T1/2 
cells, which was attenuated in the cells that were pretreated with IFNβ or IFNω. Similarly, 
IFNβ pretreatment of mESCs (D3) protected the cells from subsequent LACV-induced 
cell death in a dose-dependent manner (Figure 23B). Similar effects were observed with 
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IFNω (data not shown). These results suggest that mESCs can mediate the antiviral 
effects of type I IFNs like differentiated fibroblasts. 
 
Figure 23. IFNβ and IFNω protect 10T 1/2 cells and mESCs from LACV induced cell 
death. A, 10T1/2 cells were pretreated with or without IFNβ or IFNω for 24 h. They were 
then infected with LACV (m.o.i.=1). B, D3 cells were pretreated with different 
concentrations of IFNβ for 24 h. The cells were then were infected with LACV 
(m.o.i.=10). Viable cells in both A and B were determined at 48 h post infection by 
toluidine blue cell staining. The control (Con) represents cells without viral infection. The 
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values are means ± SD of a representative experiment performed in triplicates. The 
experiments were performed at least twice with similar results. 
IFNβ Represses Viral Replication in both 10T1/2 Cells and mESCs   
To determine the molecular and cellular mechanisms that protect the cells from 
cytopathicity of LACV infection, the effects of IFNβ on LACV replication were analyzed. 
By analyzing the titer of viruses released to the medium from LACV infected cells, these 
results showed that the viral load was significantly reduced in both 10T1/2 cells and 
mESCs that were pretreated with IFNβ (Figure 24A). The repression of viral replication 
by IFNβ was further confirmed by reduced expression of a LACV gene that encodes an 
M-segment protein (Gc protein) (Soldan et al., 2010). As shown in Figure 24B, the 
expression of Gc protein was detected in a large population of mESCs exposed to LACV. 
Pretreatment of the cells with IFNβ dramatically reduced the number of these cells, 
paralleling with the reduced viral titer as shown in Figure 24A. Then, the effects of IFNβ 
on LACV-induced expression of IFNα and IFNβ were analyzed. In 10T1/2 cells, LACV 
induced dramatic increase of both IFNα and IFNβ. Pretreatment with either IFNβ or 
IFNω reduced the IFNα and IFNβ level by ~75% in 10T1/2 cells. On the other hand, 
mESCs did not express IFNα or IFNβ in response to LACV infection (Figure 24C), and 
pretreatment with either IFNβ or IFNω had no effect on IFNα or IFNβ induction.  
Therefore, IFNβ or IFNω can protect ESCs from LACV’s cytopathic effect, but 
they do not alter the deficiency of ESCs in expressing type I IFNs (Wang et al., 2013). 
Additional experiments demonstrate that IFNβ also repressed the replication of West Nile 
Virus (WNV) in mESCs and in 10T1/2 cells. In comparison with LACV (Figure 24A), 
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the inhibitory effect of IFNβ on WNV replication in mESCs is less potent, but the effect 
is significant and consistent (Figure 24D).   
 
Figure 24. IFNβ represses viral replication in 10T1/2 cells and mESCs. 10T1/2 and D 3 
cells were pretreated with 5000 U/ml IFNβ or IFNω for 24 h followed by infection with 
LACV at m.o.i. of 1 and 10, respectively (A-C) or followed by infection with WNV at the 
m.o.i. of 1 and 5, respectively (D). A, The viral titers in the medium collected at 24 h of 
infection were determined by plaque assay. The values are means ± SD of three 
independent experiments. B, Cells expressing LACV Gc protein (the populations above 
 93 
the dotted lines) were detected by flow cytometry at 24 h post infection. The control (Con) 
represents cells without viral infection. C, The induction of IFNα and IFNβ mRNA by 
LACV infections was determined by RT-qPCR at 12 h post infection. The mRNA level in 
Con is designated as 1. The values are means ± SD of three independent experiments. D, 
The viral titers in the medium collected at 24 h post infection were determined by plaque 
assay. The values are means ± SD of three independent experiments. The difference is 
considered to be statistically significant when p<0.05 (*). 
Viral Infection Induced Antiviral Molecules in 10T1/2 Cells and mESCs and the Effect of 
IFNβ 
In response to viral infection, host cells use various mechanisms to limit viral 
infectivity. Viral infection-induced ISGs play key roles in host antiviral activities. The 
author examined three well-characterized ISGs; 2'-5'-oligoadenylate synthetase 1 (OAS1), 
which activates ribonuclease L (RNase L), thereby hydrolyzing cellular and viral RNA; 
PKR, which inhibits protein synthesis and host cell proliferation, thereby limiting viral 
replication; and ISG15, which is a ubiquitin-like protein that leads to the degradation of 
both host and viral proteins (Garcia et al., 2007; Samuel, 2001; Skaug & Chen, 2010). As 
shown in Figure 25A, LACV infection caused significant upregulation of Pkr, Oas1a, 
and Isg15 in 10T1/2 cells, which were slightly potentiated by IFNβ pretreatment. On the 
other hand, none of these three genes in mESCs were induced by LACV infection. 
However, they were induced by several folds when the cells were pretreated with IFNβ 
(Figure 25B).  
A logical explanation for the above results is that LACV-induced type I IFNs, via 
autocrine signaling, were responsible for the expression of Pkr, Oas1a, and Isg15 in 
LACV infected 10T1/2 cells (Figure 25A, LACV) while the induction in LACV-induced 
cells with IFN pre-treatment is the combined effect of autocrine and exogenously added 
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IFNs (Figure 25A, IFNβ LACV). On the other hand, the expression of the three genes in 
mESCs was not induced by LACV infection due to the deficiency of these cells in 
expressing IFNs (Wang et al., 2013) (Figure 25B, LACV), but they can be induced by 
exogenously added IFNβ (Figure 25B, IFNβ LACV), indicating that mESCs can detect 
and respond to IFNβ.  
 
Figure 25. LACV infection induced antiviral molecules and the effects of IFNβ. 10T1/2 
cells (A) and D3 cells (B) were infected with LACV at m.o.i. of 1 and 10, respectively 
(LACV), or they were pretreated with 5000 U/ml IFN  for 24 h followed by infection 
with LACV (IFNβ + LACV) for 12 h. The mRNA levels of the PKR, ISG15 and OAS1a 
were determined by RT-qPCR. The results are expressed as fold-activation where the 
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mRNA level in control cells (Con, cells without viral infection) is designated as 1. The 
values in A are means ± SD of a representative experiment performed in triplicates. The 
experiments were performed at least twice with similar results. The values in B are means 
± SD of three independent experiments. 
IFNβ Induced ISG Expression and its Priming Effect in mESCs  
To further test the responsiveness of mESCs to IFNβ, The author examined the 
effects of IFNβ on the expression of Pkr, Oas1a, and Isg15. As illustrated in Figure 26, 
IFNβ induced the transcription of the three genes in 10T1/2 cells as a positive control 
(Figure 26A). This effect was observed similarly in two different lines of mESCs (Figure 
26B, D3 and DBA) although the magnitude of induction of the three genes in mESCs is 
lower than in 10T1/2 cells. Further analysis by Western blot showed that IFNβ increased 
PKR protein level in a dose dependant manner in both mESCs and 10T1/2 cells, 
paralleling with its mRNA induction (Figure 26C).  
In differentiated cells, it is known that the pretreatment of cells with type I IFNs 
enhances their antiviral activities to the subsequent viral infection, a phenomenon known 
as the IFN priming effect (Samuel, 2001). Our results from LACV infection experiments 
indicate that the priming mechanism is functional in both 10T1/2 cells and mESCs 
(Figure 23). The priming effect is partly attributed to the upregulation of viral RNA 
receptors in addition to the induction of ISGs. To confirm the priming mechanism in 
mESCs, mESCs were primed with IFNβ followed by treatment of polyIC as a viral RNA 
mimic. As shown in Figure 26D, polyIC alone only slightly induced the expression of 
Rig-I and Tlr3 (two major receptors for viral RNAs). However, its effect was strongly 
potentiated in the cells that were pretreated with IFNβ, a pattern that fits well with the 
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IFN priming described in differentiated cells (Stewart, Gosser, & Lockart, 1971). 
However, priming mESCs with IFNβ did not result in the expression of IFNβ in response 
to polyIC (data not shown). 
  
Figure 26. IFNβ induces ISG expression and its priming effects. 10T1/2 cells (A) and 
two different mESC lines (D3 and DBA cells) (B) were treated with 5000 U/ml IFN  
for 12 h. The mRNA levels of PKR, ISG15 and OAS1a were determined by RT-qPCR. 
The results are expressed as fold-activation where the mRNA level in control cells (Con, 
cells without IFNβ treatment) is designated as 1. The values in A are means ± SD of a 
representative experiment performed in triplicates. The experiments were performed at 
least twice with similar results. The values in B are means ± SD of three independent 
experiments. C, IFNβ -induced PKR was analyzed by Western blot β-actin was used as a 
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control for protein loading. D, D3 cells were transfected with polyIC (300 ng/ml) or 
treated with IFNβ 5000 U/ml) separately, or pretreated with IFNβ 5000 U/ml) for 24 h 
followed by polyIC transfection. The mRNA levels of PKR, ISG15 and OAS1a were 
determined by RT-qPCR at 12 h incubation. The results are expressed as fold-activation 
where the mRNA level in Con is designated as 1. The values are means ± SD of a 
representative experiment performed in triplicates. The experiments were performed at 
least twice with similar results.  
The Relative Expression Levels of Type I IFN Signaling Molecules in mESCs and 10T1/2 
cells 
All of the results thus far demonstrate that the signaling pathways that mediate the 
effects of type I IFN are functional in mESCs. However, the levels of ISGs induced by 
IFNβ in mESCs are notably lower than in 10T1/2 cells.  
 
Figure 27. The relative expression levels of type I IFN signaling molecules in mESCs 
and fibroblasts. A, the relative mRNA levels of indicated genes in D3 cells and 10T1/2 
cells were determined by RT-qPCR. The relative mRNA level of each gene between the 
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two cell types was compared after normalization to β-actin mRNA in each cell type. The 
results are means ± SD of three independent experiments. The difference is considered to 
be statistically significant when p<0.05 (*). B, The RT-PCR products (obtained from the 
reactions before reaching plateau phase) of indicated genes in each cell type were 
analyzed by agarose gel electrophoresis. The relative abundance of each gene was 
compared to β-actin in each cell type (i). C, The expression of STAT1 was determined by 
flow cytometry after the cells were first immunostained with anti-STAT1 antibodies 
followed incubation with FITC-labeled secondary antibodies. The expression level was 
proportional to florescence intensity. The control (Con) represents cells without 
STAT1antibodies.   
To determine the reasons for these discrepancies, the basal expression levels of 
the major signaling molecules in the IFN pathway were analyzed. As shown in Figure 27, 
quantitative RT-qPCR analysis indicated that the mRNA of Ifnar1, Jak1, and Stat1 are 
expressed at comparable levels in D3 cells and 10T1/2 cells, while the mRNA levels of 
Tyk2, Stat2, and Irf9 are actually higher in D3 cells than in 10T1/2 cells. The only gene 
with low mRNA expression in D3 cells is Ifnar2 (Figure 27A). A comparative analysis of 
two lines of mESCs (D3 and DBA) and two types of fibroblasts (MEF and 10T1/2) 
showed that the mRNA of all the genes tested in each cell line are expressed at relative 
high abundance compared to β-actin, a housekeep gene that are expressed at a very high 
level (Figure 27B). At the protein level, STAT1, a major transcription factor that 
mediates the effects of type I IFNs, was readily detected with its antibody in 10T1/2 cells 
and D3 cells, with a slightly higher expression level in D3 cells as determined by flow 
cytometry (Figure 27C).  
Different Induction Patterns of ISGs in mESCs and 10T1/2 Cells 
To further characterize ISG expression, their induction patterns in IFNβ treated 
mESCs and 10T1/2 cells in a 24 h time course were compared. As shown by Figure 28, 
 99 
the mRNA of Pkr and Isg15 were quickly induced in both cells by IFNβ at 4 h. However, 
they quickly declined to ~50% of the maximal activation in 10T1/2 cells at 8 h, but the 
mRNA level of the two genes in mESCs were sustained (Figure 28, A and B).  
 
 
Figure 28. Expression patterns of ISGs in mESCs and fibroblasts. D3 and 10T 1/2 cells 
were treated with 5000U/ml IFNβ for indicated time points as indicated. The relative 
mRNA levels of ISG15 (A), PKR (B), and of SOCS1(C) were analyzed by RT-qPCR.  
The results are expressed as fold-activation where the mRNA level in control cells is 
designated as 1. The values in A and C are means ± SD of three independent experiments. 
The values in B and C are means ± SD of three independent experiments The values of A 
are means ± SD of a representative experiment performed in triplicates. The experiments 
were performed twice with similar results. The gel insets in C are RT-PCR products of 
SOCS1 analyzed by agarose gel electrophoresis. The control (Con) represents cells 
without IFNβ treatment. 
The author further tested the expression patterns of Socs1, a negative regulator of 
IFN signaling. As shown in Figure 28C, Socs1 was induced by IFNβ at 4 h in 10T1/2 
cells, but such induction was not observed until 24 h in mESCs. It is well established that 
SOCS1 strongly inhibits ISG expression, thereby limiting the strength and duration of 
IFN response (Kubo, Hanada, & Yoshimura, 2003). The expression pattern of Socs1 
explains the induction dynamics of Pkr and Isg15 in 10T1/2 cells since the induction of 
Socs1 at 4 h coincided with the decline of Pkr and Isg15. On the other hand, delayed 
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induction of Socs1 in mESCs could account for the sustained expression of Pkr and Isg15 
(Figure 28, A and B). While IFNβ induced ISGs and SOCS1 in 10T1/2 cells displayed a 
typical patterns as seen in other differentiated cells, the results from mESCs are 
“unconventional” although the basal mRNA level of Socs1 is comparable in two cell 
types.  
IFNβ Potentiates dsRNA-inhibited Proliferation of mESCs 
PolyIC has been shown to activate PKR, thereby inhibiting mESC proliferation, 
although it cannot induce IFNβ in mESCs (Wang et al., 2013).  
 
Figure 29. IFNβ potentiates polyIC-inhibited proliferation of mESC. A, D3 cells were 
transfected with 300 ng/ml polyIC alone (PolyIC), or pretreated with IFNβ 5000 U/ml) 
for 24 h followed by polyIC transfection (IFNβ/PolyIC). The cells with phosphorylated 
eIF2α (p-eIF2α were quantified by flow cytometry (boxed areas. White slash lines were 
used to help identify the bottom sides of the boxes) at the times indicated. B, The cells 
treated under the condition described in A at 24 h were analyzed for cell cycle by flow 
cytometry. The change in G2/M phase cells was indicated by the arrow. C, The numbers 
of viable cells in the samples described in B were determined by toluidine blue cell 
 101 
staining. The values are means ± SD of a representative experiment performed in 
triplicates. The experiments were performed at least twice with similar results. The 
control (Con) represents cells without any treatment. 
Since IFNβ induces PKR expression, the author assumed that treatment of mESCs 
with IFNβ would augment the effect of polyIC. To test this hypothesis, PKR activity was 
determined by the phosphorylation of eukaryotic initiation factor 2α (eIF2α, a known 
substrate of PKR) (Wang et al., 2013). 
As shown in Figure 29, polyIC transfection caused eIF2α phosphorylation in 
mESCs at 6 h and 24 h, which were potentiated in the cells that were pretreated with 
IFNβ (Figure 29A, PolyIC and IFNβ/PoyIC, respectively, boxed areas). Accordingly, 
polyIC by itself caused a significant reduction of cells in the G2/M phases, which was 
further augmented by IFNβ (Figure 29B, PolyIC and IFNβ/PoyIC, respectively, indicated 
by arrows). The inhibitory effect on cell cycle was reflected by reduced cell proliferation 
where IFNβ pretreatment caused slight but statistically significant additional effect to 
polyIC alone (Figure 29C). These results further confirm the functionality of the 
molecular mechanisms that mediate the effects of IFNβ in mESCs.    
Type I IFNs Do not Affect Unique Properties of mESCs   
Type I IFNs have been best characterized as immunomodulators, but they also 
regulate other cellular processes (Platanias, 2005). To test if they have any effect on the 
properties of mESCs, the effects of IFNβ and IFNω on the expression of pluripotency 
markers and cell proliferation were examined. mESCs are characterized by their rapid 
cell proliferation rate with about 60% of cells in the S phase, and they grow in compacted 
colonies (Stead et al., 2002).  
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Figure 30. Type I IFNs do not affect the stem cell state of mESCs. D3 cells were treated 
with IFNβ or IFNω 5000 U/ml) for 24 h or 48 h. The cells were then analyzed for: A, cell 
cycle progression by flow cytometry, B, cell proliferation by toluidine blue cell staining 
(24 h treatment), C, cell/colony morphology analysis by microscopy (48 h treatment), D 
and E, the mRNA levels of pluripotency markers by RT-qPCR in the cells that were 
treated with IFNβ for 48 h once (D) or twice (2x 48h) (E). The results are means ± SD of 
three independent experiments (D) or a representative experiment performed in triplicates 
(E). PKR was used as a positive control. The control (Con) represents cells without IFNβ 
treatment. 
As shown in Figure 30, neither IFNβ nor IFNω affected the cell cycle profile (A), 
cell proliferation (B), or colony morphology (C). Similarly, the expression levels of the 
pluripotency markers unique to ESCs were not affected either by a short period single 
treatment with IFNβ (Figure 30D, 48 h) or by two consecutive treatments, while PKR (an 
ISG as a positive control) was induced by IFNβ treatment (Figure 30E, 2x 48h). Similar 
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results were obtained in DBA cells (data not shown) or when the cells were treated with 
IFNβ. Therefore, type I IFNs do not affect the stem cell state of mESCs. 
Discussion 
The ability to produce and respond to type I IFNs as a critical component of innate 
immunity is presumably developed in all types of mammalian cells. However, our studies  
in mESCs and those of other investigators in hESCs have revealed that these cells are 
deficient in expressing type I IFNs, indicating that the “innate immunity” is not, or at least 
not fully, developed in ESCs (Chen et al., 2010; Wang et al., 2013). This finding revealed 
a unique property of ESCs that has not been previously characterized. In this chapter, the 
responses of mESCs to type I IFNs were investigated.  
 A recent study reported that hESCs have substantially attenuated response to 
IFNβ as judged by their negligible expression of ISGs, but the antiviral activity of IFNβ 
was not tested against live viral infection (Hong & Carmichael, 2013). However, it is 
interesting to note that two early brief studies in mESCs have indicated that these cells 
can respond to IFNβ, but they attracted little attention in the early days of ESC research 
(Ruffner, Reis, Naf, & Weissmann, 1993; Whyatt, Duwel, Smith, & Rathjen, 1993). The 
molecular mechanisms involved and physiological implications of these findings in 
ESCs are not known. Based on multiple criteria, the results presented in this chapter 
demonstrate that mESCs have the basic functional mechanisms to respond and to 
mediate the effects of type I IFNs. At the cellular level, IFNβ and IFNω can protect the 
cells from LACV-induced lytic cell death and repress viral replication of LACV and 
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WNV. At the molecular level, mESCs express the major signaling components of the IFN 
pathway. More importantly, mESCs are able to express ISGs, which is the hallmark of 
IFN action and the molecular basis for the antiviral activity of type I IFNs.  
Therefore, IFNβ and IFNω can induce major responses in mESCs like in 
differentiated cells although the magnitude of ISG induction in mESCs is generally lower 
than in fibroblasts.  
 In hESCs, the major signaling molecules of the IFN pathway are expressed at 
relatively lower levels than in differentiated cells; however, the failure of hESCs to 
respond to IFNβ is mainly attributed to the high expression level of suppressor of 
cytokine signaling 1 (SOCS1) (Hong & Carmichael, 2013). In differentiated cells, 
SOCS1 is expressed at a low basal level in the resting cells, but it is rapidly induced and 
acts as a negative regulator of JAK/STAT signaling upon stimulation with IFNs or viral 
infection (Kubo et al., 2003). However, hESCs constitutively express high levels, thereby 
repressing IFNβ action (Hong & Carmichael, 2013). Transcriptional analysis in mESCs 
revealed that, with the exception of Ifnar2, the mRNA of the major signaling molecules 
in the IFN pathway are expressed at comparable or even higher levels than in fibroblasts 
(10T/12 cells), whereas the mRNA of Socs1 is expressed at a basal level in mESCs that is 
similar to 10T/12 cells. These results could explain the responsiveness of mESCs to type 
I IFNs and the difference between mESCs and hESCs.  
Currently the reasons for the low levels of ISG induction by IFN in mESCs are 
still elusive, but this result is not surprising due to the multiple level regulation of ISG 
 105 
expression. It is likely that some mechanisms required for maximal ISG expression may 
have not yet fully developed in mESCs. It is also possible that IFN response systems in 
mESCs and differentiated cells could be modulated via different regulatory mechanisms.  
However, a more plausible reason could be closely related to the defective IFN 
expressing mechanism in mESCs. In differentiated cells, the cellular responses induced 
by exogenous IFNβ can be strongly potentiated by the cellular expressed IFNs through 
autocrine signaling (Samuel, 2001; Stetson & Medzhitov, 2006). Therefore, in IFN 
primed (or virally infected) 10T1/2 cells, the ISG induction is the collective effects of 
exogenously added IFNβ and endogenously expressed cellular IFNs, whereas the ISG 
induction in mESCs is solely due to exogenously added IFNβ since these cells are 
deficient in expressing type I IFNs (Wang et al., 2013). 
In differentiated cells, it is known that the signaling molecules in immune 
responses are upregulated by the initial stimulus via a positive feedback loop (Huang et 
al., 2006; Matsumoto & Seya, 2008; Pan et al., 2011). Through paracrine and autocrine 
signaling mechanisms, IFNβ induced from the initial antiviral response can boost the 
antiviral responses of the infected cells and prime uninfected cells to enter the antiviral 
state (Samuel, 2001; Stetson & Medzhitov, 2006). A critical part of this mechanism is the 
upregulation of viral sensing receptors in primed cells. Using polyIC as viral stimuli, the 
upregulation of Rig-I and Tlr3 was detected in IFNβ primed mESCs, thereby 
demonstrating the existence of priming mechanism in these cells. Based on these 
observations, it can be concluded that the priming system in mESCs is operational. It is 
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noted that priming does not resulted in an increase of cellular IFNβ expression in 
response to polyIC, suggesting that deficiency of IFNβ expression cannot be corrected or 
compensated for by priming with exogenously added IFNβ. Therefore, such deficiency is 
likely a developmental issue related to the stem cell state.  
 Pretreatment of mESCs with IFNβ confers strong protection against LACV 
infection, as judged by the reduced cytotoxicity and viral replication. However, the 
antiviral effect of IFNβ in inhibiting the replication of WNV in mESCs is much lower 
than in 10T1/2 cells. The reasons for this discrepancy are not clear but could be explained 
by several possibilities. For example, it is known that the antiviral activities of IFNβ are 
cell type as well as virus dependent (Goodbourn, Didcock, & Randall, 2000; Li & Sherry, 
2010; Rose & Weiss, 2009). As previously reported, although the IFN expressing system 
is deficient, PKR can be activated by LACV infection, which could contribute to the 
antiviral activities of IFNβ in LACV-infected mESCs (Wang et al., 2013), whereas, 
WNV infection did not activate PKR in mESCs as in other rodent cells (Elbahesh et al., 
2011; Wang et al., 2013). It is possible that the lack of PKR activation in WNV-infected 
mESCs may account for the weaker antiviral activity of IFNβ.  
 In addition to participating immune responses, type I IFNs also regulate several 
other important biological processes (Platanias, 2005). Whether and how they affect the 
unique properties of ESCs have not been previously investigated. The results suggested 
that neither IFNβ nor IFNω treatment affected the three distinctive features of mESCs – 
rapid cell proliferation rate, colony morphology, and pluripotency. However, it should be 
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pointed out that these experiments were conducted in the presence of LIF that represses 
cell differentiation. The outcome could be different if the experiments are conducted with 
differentiating cells in the absence of LIF.  
 hESCs and mESCs share fundamental similarities in pluripotency and self 
renewal, but they also show species differences in two important aspects. First, activation 
of the JAK/STAT3 pathway by LIF (which shares the similar signaling paradigm with 
IFN) is essential for the maintenance of self-renewal and pluripotency in mESCs, but is 
not required for hESCs (Daheron et al., 2004; Humphrey et al., 2004; Matsuda et al., 
1999). Second, mESCs are characterized by a shortened cell cycle whereas hESCs have 
time frame similar to differentiated cells (Burdon, Smith, & Savatier, 2002; Dalton, 2009; 
Singh & Dalton, 2009). The difference in responding to type I IFNs in mESCs (this study) 
and in hESCs represents a new distinctive feature in ESCs from the two species (Hong & 
Carmichael, 2013). At the present time, the implications of this difference in embryo 
development and reasons for this discrepancy in human and mouse remain to be 
determined.  
 In summary, this study demonstrates that cellular mechanisms in type I IFN 
production and action are differentially developed in mESCs (Wang et al., 2013). They 
are deficient in expressing type I IFNs but have the basic mechanisms to mediate the 
cellular effects of type I IFNs although these mechanisms may not yet be fully developed. 
These findings imply that, while mESCs are unable to produce type I IFNs to confer 
antiviral activities to themselves and their neighboring cells, they are able to acquire 
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antiviral effects from type I IFNs secreted from other cells (via paracrine mechanism). 
While it is not clear about physiological implications for mESCs not having the ability to 
produce type I IFNs, being able to acquire the antiviral activities from these cytokines 
could be an advantage for mESCs. These findings bring up an important subject in ESC 








In the three related projects, the author first studied the immune responses of 
mESCs to live viruses and different synthetic viral RNA analogues, with emphasis on 
their ability to express type I IFN. Then examined how mESCs respond to type I IFN and 
tested whether they can be protected by IFNs from viral infection were examined. Overall, 
the findings confirmed deficient anti-viral response which is centered by induction of 
type I IFN in mESCs although they are partially responsive to type I IFN and the 
following protection from certain types of viral infection. Together with the findings in 
hESCs and in other pluripotent cells in early years, it can be concluded that the deficiency 
in type I IFN signaling is likely a characteristic of mammalian pluripotent cells (Burke, 
Graham, & Lehman, 1978; Chen et al., 2010; Hong & Carmichael, 2013). While the type 
I IFN-related anti-viral activity is under-developed in pluripotent cells, they have been 
reported to utilize RNA interference (RNAi) to combat viral infection (Li, Lu, Han, Fan, 
& Ding, 2013; Maillard et al., 2013). During natural development, differentiated somatic 
cells acquire fully functional type I IFN signaling which becomes the major anti-viral 
player of innate immunity, while anti-viral effects of RNAi diminish, as supported by the 
finding that defective RNAi mutation in differentiated cells does not rescue the growth of 
viruses with mutant suppressor of RNAi (Pare & Sullivan, 2014). In human differentiated 
cells, Argonaute2 (Ago2) which is a key component of RNA induced suppressor complex 
(RISC), is inhibited during stress and pathogen infection (Leung et al., 2011; Mazumder, 
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Bose, Chakraborty, Chakrabarti, & Bhattacharyya, 2013; Seo et al., 2013). Pluripotent 
stem cells seem to use different strategies from their progeny to fight against viral 
infection.  
It is interesting to note that IFN pathways are evolutionarily young and only exist 
in vertebrates, while RNAi is widely used by many metazoans including plants and 
invertebrates to combat viruses. Thus, mammalian pluripotent cells seem to share 
anti-viral strategies with invertebrates and plants. The advantage of RNAi anti-viral 
strategy in pluripotent cells may lie in avoiding side effects of IFN signaling on 
proliferation, higher efficiency in defending against transponsons and preventing 
sacrifice of the lineage due to some harmless triggers such as cytoplasmic cellular 
dsRNA, which can be detected in pluripotent cells (Chen & Carmichael, 2009; Chen et 
al., 2010; Hertzog, Hwang, & Kola, 1994).  
The current research just begins to reveal the anti-viral responses in pluripotent 
stem cells. More importantly, the development of anti-viral immunity and fully 
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